News index
- Lupus Foundation of America Announces Capability to Accept Cryptocurrencies
- Kids with Lupus Need Mental Health Support
- 2016 Lupus Insight Prize Presented to Dr. Ann Marshak-Rothstein
- 21st Century Cures Act Signed into Law
- Atacicept Study Data Shows Promising Results
- Aurina Announces Plans for Single Phase III Clinical Trial for Voclosporin
- New promising study results: Cognitive impairment in kids with lupus
- FDA Approves BENLYSTA as a Weekly Self-Administered Injection to Treat Lupus
- New Grants Announced to Support Research in Pediatrics and Underrepresented Communities
- LFA-Funded Study Helps Expedite Drug Development
- Foundation Issues Request for Applications to Advance Research in Pediatric Lupus Nephritis
- Why it matters when celebrities go public about their lupus
- Voclosporin Clinical Study Achieves High Complete Remission Rates for Lupus Nephritis
- Study Reveals Shockingly High Rates of Incorrect Lupus Diagnosis
- 1st Anniversary of the First Open Access Online Research Journal Dedicated to Lupus
- Alexis Teixeira: Lupus in the fast lane
- LFA Research Improving Clinical Trial Design
- Alison Eckberg: Team Make Your Mark Champion
- Allie Gutshall: My Fight for Life
- It’s time to get connected
- Dan Walmer: Evolution of an Athlete
- Danica Winkley: Big Miles for a Big Purpose
- Encouraging Diversity in Clinical Trial Participation
- 10 of our favorite quotes from Fabulupus
- Finding Hope After Diagnosis
- Reducing Steroids Associated with Lower Healthcare Costs in Lupus Treatment
- Phase IIB Clinical Trial of Voclosporin Successfully Achieves Primary Endpoint
- New study results: Reducing burden of quality of life reporting for adolescents
- Danica Winkley: Running to Honor Her Sister
- For Someone You Love…
- Get Fit: The Summer to Start Anew
- Guest Blog: Climbing Kilimanjaro for Lupus Awareness
- Hispanic Heritage Month
- Ian Harding: Why I Support the Lupus Foundation of America
- Lorenzo Hall: Dancing Helps Me Express Myself
- Meet the Lupus Researcher Working to Save Children’s Lives
- Make Your Mark™ in the Fight Against Lupus
- Making a Positive Impact with Mom by My Side
- Man Surprises Girlfriend with Lupus with Proposal, Wedding in One Night
- Maurissa Tancharoen Whedon: A Little Miracle for Mother’s Day
- NFL Stars Auctioning Off Lupus Awareness Cleats
- Nicole Arceneaux: “I’ve finally decided I’m tougher than lupus”
- Nicole Kleinhen: Cartwheels for Cures
- Putting PJs to Work
- Shannon Boxx: I want a cure
- Sharing the Journey
- Sharing the Journey: Allergy Season
- Sharing the Journey: Avoiding Raynaud’s During the Winter
- Sharing the Journey: Challenges to Eating Healthy
- Sharing the Journey: Explaining Lupus
- Sharing the Journey: Giving Thanks to…
- Sharing the Journey: Lupus Brain Fog
- Sharing the Journey: Managing Holiday Stress
- Sharing the Journey: New Year's Resolution
- Sharing the Journey: New Year’s Resolutions
- Sharing the Journey: Pediatric to Adult Care
- Sharing the Journey: Raising Lupus Awareness
- Sharing the Journey: Relationships
- Sharing the Journey: Research Participation
- Sharing the Journey: Social Support
- Sharing the Journey: Time Machine
- Sharing the Journey: Life Decisions
- Sharing the Journey: Healthy Habits
- We Remember Dr. Evelyn Hess – A Pioneer in Lupus Research
- Access to Treatments
- Actor, Comedian, and Musician Nick Cannon Diagnosed with Lupus Nephritis
- Corporations Partner to Facilitate Earlier Diagnosis of Lupus
- 2017 Appropriations Act Includes Support for Lupus Research
- Dr. Graciela S. Alarcón Receives Award Recognizing a Lifetime of Achievement in Lupus Research
- Dr. Bruce Richardson Receives Lupus Insight Prize Recognizing Outstanding Contribution in Research
- Dr. George Tsokos Receives Lupus Insight Prize Recognizing Outstanding Contribution in Research
- Dr. Mark J. Shlomchik Selected as the First Recipient of the Lupus Insight Prize
- Hollywood Phenom Maurissa Tancharoen Whedon Fights Lupus
- In Memory of Marilyn Sousa
- LFA Awarded Multi-million Dollar Grant to Build Lupus Awareness and Improve Quality of Life
- Los Angeles Chargers Star Antonio Gates to Promote Lupus Awareness with Custom Cleats
- Lupus Community Shares Views with FDA at Historic Patient-Focused Drug Development Meeting
- Five New Research Studies Funded to Improve Quality of Life for People with Lupus
- Make Your Mark™ Turns Events into Fundraising Opportunities to Solve the Cruel Mystery of Lupus
- NIH Datasets Will Accelerate the Quest for New Lupus Treatments
- Professional Soccer Player and Olympic Gold Medalist Shannon Boxx Scores New Goal As Lupus Awareness
- Selena Gomez announcement focuses attention on lupus’ mental health impact
- With announcement, Selena Gomez highlights mental health impact of lupus
- Top Lupus Researchers Recognized For Exceptional Achievement
- Two Prominent Investigators Recognized For Their Achievements In Lupus Research
- "UNVEIL" Survey Reveals a Life Interrupted by Lupus
- WebMD: Nick Cannon Winning the War With Lupus
- We're partnering with The Mighty!
- Major Lupus Stem Cell Study Receives Funding
- Study Leads to a New Approach for Evaluating the Effectiveness of Experimental Therapies
- New Study: Predicting Risk of Miscarriage During First Trimester
- Study Supports Alternative Method for Estimating Treatment Effects in Clinical Trials
- Mid-stage Clinical Trial of DZP Misses Primary Endpoint
- Lupus Foundation of America Appoints Stevan Gibson as President
- Make Your Mark: Hudson Valley Walks to Fight Lupus
- Here Comes the Sun (and Your Photosensitivity)
- Kendall Eilerman: Fundraising Champion
- Kevin Davis: Walking for a Purpose
- Learn How Our Research on Lupus Kidney Disease Helps Patients Now!
- Lupus in Lights
- New Guidance on Sun Safety
- Lupus: The Musical
- Kylie Katz: “I won’t let lupus define who I am”
- Make Your Mark With Pokemon Go
- Michigan Nurse Sees the Devastating Effects of Lupus First-Hand
- About the National Lupus Advocacy Summit
- New Year, New Education Series
- My Wish: No More Families Torn Apart by Lupus
- Painting with a purpose
- Pennsylvania Woman with Lupus Wins Dress Designed by Project Runway Winner
- PhRMA Research and Hope Awards
- Progress Toward a Life Free of Lupus: 2015 Top Ten Achievements in Research, Education and Advocacy
- Regulations for Off-Label Drugs Must Change
- Rick Lyons: Walking Toward Hope
- Rodeilyn Rosario: A Special Proposal
- Shannon Small: Walking Toward Acceptance
- Shemiah Sanchez: Against All Odds
- 6 Sensible Sunscreen Tips
- Taking Control of Your Health: Why Lupus Awareness Matters
- The 365th Day
- What Does Research Mean to You?
- Youth Advocates Shine at Evening of Hope Gala
- Woman with Lupus to Receive Life-Changing Transplant
- LFA-Supported Researchers Share Promise for Future Lupus Treatments and Cure
- World Premier Rheumatology Meeting Inspires Hope
- Dr. Bruce Richardson Selected as the Second Recipient of the Lupus Insight Prize
- $5 Million for Lupus Research Passes Second Critical Hurdle
- Congress Set to Approve $13 Million for Lupus
- Congressional Lupus Caucus Launched in U.S. House of Representatives to Advance Awareness of Lupus
- Free Yourself From Pain... It's Pain Awareness Month
- Inactivity, Isolation and Impact on Daily Life are Top Concerns for People Living with Lupus
- Musician and Philanthropist Julian Lennon to Elevate the Global Profile of Lupus
- Foundation Responds to Eli Lilly and Company’s Release of Data from Clinical Trial of Tabalumab
- Low Public Understanding of Lupus Hinders Progress
- Mortality in Lupus: The Untold Story
- Announcing a New Initiative to Improve Health and Quality of Life
- Changes Ahead for the Nutrition Facts Label
- Swim, Bike, Run – Doing Anything He Can To Help End Lupus
- Sarah - Diagnosed Age 17
- Joslyn - Diagnosed Age 16
- Amarissa Mauricio: A Fighting Spirit
- Dan: The Long Road to Diagnosis - and Acceptance
- Gaining More by Giving Back
- We Can and Will Solve the Cruel Mystery
- Jadian - Diagnosed Age 23
- Brett - Diagnosed Age 17
- Award Supporting Early Career Scientists Aims to Reduce Future Shortage of Lupus Researchers
- Dr. Joan Merrill: Championing New Treatments for Lupus
- Jackie Brown: Shining a Light on Lupus
- Victoria Gibbs: The long road to diagnosis
- Audrey Ayala: Lifeline for a Warrior
- Bonnie Kassel: “Taylor-made” reason to take a stand
- Toni Grimes: Retired - and Still Making a “Major” Difference
- Josie Pearce: Finding Acceptance and Support
- Fresh Air and Fundraising, for the Love of her Mom
- A special bond: Actor Ian Harding supports his mom through lupus advocacy
- Barbara - Diagnosed Age 18
- Cindi - Diagnosed Age 22
- Lupus Experts Present Consensus Proposals to FDA for Advancing Clinical Trials and Health Outcomes
- Exagen Diagnostics and CareFirst Team Up to Study AVISE Lupus Test
- DOD Releases Pre-Announcement of FY 2018 Lupus Research Funding Opportunities
- Join Us in Moving Research Forward
- International Survey Shows Low Global Understanding About Lupus
- Major Lupus Stem Cell Study Receives Additional Funding from the National Institutes of Health
- New Study Finds Lupus is a Leading Cause of Death Among Young Women
- LIFELINE Grant Recipient Secures $6.7 Million from NIH for Lupus Research
- Lupus Scientist Receives Prestigious Award; Young Investigator also Recognized for Contributions
- Lupus Foundation of America Supported Grant Finds Lupus is an Unrecognized Cause of Death in Women
- Barbara Bush: A Tribute to Her Support of People with Lupus
- New Study Seeks to Determine Effectiveness of Synthetic Cannabinoid in Relieving Joint Pain in Lupus
- Mallory Nwaokai: Making Her Mark in 2018
- The Lupus Foundation of America Elects Two New Members to its National Board of Directors
- Six Young Scientists Receive Award to Build the Next Generation of Lupus Researchers
- Walking for Herself and for Every Person Fighting
- Lupus Foundation of America Responds to Release of Data from Trial of Anifrolumab
- Tiana - Diagnosed Age 29
- Living an active life despite lupus
- Making a Difference to Honor His Mom
- Eduardo Xol created a zen retreat for his sister living with lupus
- Cindy Coney: Finding the energy to play
- Josie Pearce: Finding the power to stay positive
- Brittany Wolf: From patient to provider
- Sharing the Journey: Tips for Staying Healthy During Flu Season
- Valentina Vergati: Lupus means more than textbooks can tell you
- Her diagnosis brought them closer
- Sharing the Journey: Explaining Lupus to Others
- Janice Wolfe-Easley: Scrapbooking strengthens my spirits
- Jessica and Jen: A friendship strengthened by disease
- Jessica Kundapur and Jodie Nimigon-Young: How to be fabulupus
- Joy Cameron: Shine your light
- Julian Lennon and Lucy’s legacy
- Life as a man with lupus
- How Maurissa Tancharoen Whedon became an advocate for lupus
- Nikki Waitt: Power to persevere
- Leading Lupus Experts Propose Actionable Solutions to Improve Clinical Trials
- I have lupus: Now what?
- Parenting and back to school
- Savannah Knudtson: Speaking up about lupus
- How Selena Gomez’s lupus led to a kidney transplant
- Self-esteem survival skills
- At-risk young women unite against lupus
- Gabriela Estefany - Diagnosed Age 17
- In Loving Memory of Charlene
- Sherrie H. - Diagnosed Age 45
- Jordin P. - Diagnosed Age 13
- Angela P. - Mother of Lupus Warrior
- Jesus P. - Diagnosed Age 22
- Elissa W. - Diagnosed Age 26
- In Loving Memory of Marco
- Stevan W. Gibson Elected to National Health Council Board
- Sharing the Journey: Managing Holiday Stress
- FDA Grants Fast Track Status to Drug Being Studied for Lupus Treatment
- Lupus Can Take a Hike
- Urinary HER2 as a biomarker for lupus nephritis (Year Four Update)
- Research, Advocacy Support – A Look Back at 2018
- NFL Stars Wear Custom Cleats for Lupus Awareness
- We Offer Condolences at the Passing of Dr. Stephen Katz, Director of NIAMS/NIH
- Study Shows Thromboelastography May Aid Coagulation Analysis in Children with Lupus
- Study Supports Antibody Testing in Obstetrical Lupus Treatment
- New Study Assesses Shingles Frequency in People Receiving CYC and Steroids
- Nick Cannon, Lupus Warrior
- Study Identifies Largest Contributors to Fatigue Among People with Systemic Lupus
- Study Identifies Gap Between Practice and Recommendations for the Care of Pregnant Women with Lupus
- Clinical Trial Reports Omalizumab Associated with Improvement in Lupus (SLE) Disease Activity
- Susan S. - Diagnosed Age 46
- Noella Q. - Diagnosed Age 36
- Sylvia F. - Diagnosed Age 31
- Study Shows that Control of Heart Health Can Improve Pregnancy Outcomes in Women with Lupus
- Study Shows Need for More Cardiovascular Disease Assessment and Treatment Among People with Lupus
- In Loving Memory of Danielle
- Bailey W. - Diagnosed Age 22
- Study Shows Rituximab May Be Effective at Treating Cutaneous Lupus Erythematosus
- Study on Belimumab Therapy Provides Further Guidance on Use for People with Lupus
- New Partnership with Alianza – Gilbert Motorsports to Drive Lupus Awareness
- Study on Cenerimod for Treatment of Systemic Lupus Erythematosus Enrolls First Patient
- Sharing the Journey: Hope in the New Year
- Scarlett S. - Diagnosed Age 3
- High-Fiber Diet Suppresses Autoimmune Disease Development
- New Disease Outcome Tool for Lupus Activity Measurement
- Study Identifies 10 Important and Current Challenges to Lupus Management
- Ismar J. - Diagnosed Age 14
- IFNalpha Kinoid Continues to be Studied for Treatment of Systemic Lupus Erythematosus
- Lupus may compromise long-term rubella immunity in adolescents
- Research Finds Decline in Deaths Due to Lupus Nephritis
- Study Identifies New Measure for Distinguishing Infection in People with Lupus
- Understanding Fatigue in Lupus: Study Promotes Looking Beyond Skeletal Muscle
- New Study Identifies Potential New Targets for Improving Heart Health in People with Lupus
- Study Underscores Need for More Research About Infection in People with Lupus
- Tanisha W. - Diagnosed Age 36
- Miguel S. - Diagnosed Age 14
- Study Finds Better Outcomes with Belimumab Therapy for People with Lupus
- Update in Childhood-Onset Lupus: Definition Established with New Tool
- Turn Capitol Hill Purple March 4 -5, 2019
- Favorable Short and Long-term Outlook for Lupus Psychosis
- Lupus Foundation of America Reinvents its Online Home
- Mike Guizar: Running for his Wife
- Study Underscores Need for Further Research in Lupus Management
- Medicaid Population Research Reports Increased Fracture Risks in People with Lupus
- Study Emphasizes Need for Proactive Cancer Screening in People with Lupus
- Research Identifies Need for More Study of Nephrotic Syndrome in People with Lupus Nephritis
- Study Calls for Heightened Monitoring for Lung Disease in People with Systemic Lupus Erythematosus
- Applications Open for 2019 Lupus Research Grants
- Sharing the Journey: Friendships & Support
- Vielka Y. - Diagnosed Age 29
- Chloe V. - Diagnosed Age 8
- Kimberly N. - Diagnosed Age 30
- Cherokee Carroll – Walking for The Days She Couldn’t
- Angel W. - Diagnosed Age 12
- A New POC Study Shows Positive Results and Supports Further Investigation into Stem Cell Research for Lupus
- Ashley L. - Diagnosed Age 26
- Deb N. - Diagnosed Age 26
- Black Children with Lupus Exhibit Higher Incidence of Pericardial Effusion
- Peripheral Nervous System Involvement is a Potential Complication of Lupus, Study Finds
- Safety of Long term use of Hydroxychloroquine Therapy Further Verified for People with Lupus
- Encouraging New Research for People with Lupus Nephritis
- Study Finds Potential Link Between Abnormal Levels of Gut Bacteria and Lupus
- Study Further Validates Tool that Supports Better Health Outcomes in Lupus
- Physical Fitness Associated with Improved Quality of Life for Women with Lupus
- Social Support in the Hospital Improves Outcomes for People with Lupus
- Exagen and the Lupus Foundation of America Partner on New Initiative to Reduce the Time to an Accurate Lupus Diagnosis
- Jamie W. - Diagnosed Age 21
- Katrina T. - Diagnosed Age 37
- Annie S. - Diagnosed Age 54
- Chavella M. - Diagnosed Age 15
- Katie A. - Diagnosed Age 17
- Assessment of Lupus Activity Measurement Tools Reveals Challenges and Opportunities for Improvement
- Exploring the Benefits of Yoga Therapy for Lupus
- Noncoding RNA Plays a Role in Lupus Disease Development
- Sharing the Journey: Rest and Relaxation
- Pamela D. - Diagnosed Age 36
- Lisa H. - Diagnosed Age 50
- Lupus Foundation of America Grant Applications Supporting Next Generation of Lupus Scientific Leaders Now Open
- Mike M- Diagnosed Age 43
- Jeff B. - Diagnosed Age 44
- Large Scale Analysis of Data Provides Valuable Insights into the Impact of Lupus on Quality of Life
- Lila M. Diagnosed Age 20
- Donna L. - Diagnosed Age 65
- Jody S. - Diagnosed Age 61
- Maria P. - Diagnosed Age 35
- Stacey M. - Diagnosed Age 37
- In Loving Memory of Meona
- Help End Lupus and Win a Chance to Visit the Set of Marvel’s Agents of S.H.I.E.L.D.
- Study Investigates Approach for Predicting Future Kidney Outcomes in People with Lupus
- Nancy B. - Diagnosed Age 36
- Resistant Hypertension in People with Lupus Associated with Higher Risk of Mortality
- Ashley L. - Diagnosed Age 20
- Examination of Disease Activity Measure Proves Need for Better Tools
- Lupus Foundation of America Hydroxychloroquine Survey Sheds Light on Need for New Dosage Forms
- CAR-T Cells in Mice Models with Lupus
- Study of Childhood Onset Lupus Confirms Unique Needs of Adolescents and Young Adults
- In Loving Memory of Tynecia
- Colleen H. - Diagnosed Age 37
- Study Examines Japanese People with Lupus
- 13th International Congress on Systemic Lupus Erythematosus - LUPUS 2019
- Kiara H. - Diagnosed Age 18
- Moving and Grooving to End Lupus
- New Treatment for Autoimmune Inflammatory Diseases Begins Phase 1 Trial in Australia
- Lupus Foundation of America Study on Hydroxychloroquine Reveals Experiential Factors are Paramount to Treatment and Adherence
- Study Finds Tacrolimus Safe and Effective for Lupus Nephritis
- Research Community Calls for Updates to EULAR Recommendations for Lupus Management
- Sharing the Journey: Tips for a Healthy Diet
- Lupus Foundation of America Comments in Support of Administration’s Plan to Reform Part D Rebate System
- Department of Defense Releases Pre-Announcement of FY 2019 Lupus Research Funding Opportunities
- Physical Exercise and Psychological Interventions Complement Usual Medical Care in Lupus
- Research Highlights from 13th International Congress on Lupus
- Doris S. - Diagnosed Age 45
- Justin B. - Diagnosed Age 22
- Elisette B. - Diagnosed Age 22
- Serena G. - Diagnosed Age 28
- Tara S. - Diagnosed Age 42
- Phase IIb IFNalpha Kinoid Study Reveals Positive Results for People with Systemic Lupus Erythematosus
- Research Finds Hydroxychloroquine Can Contribute to Improved Pregnancy Outcomes in Women with Lupus
- Kidney Biopsies Analysis Helps to Accelerate Discovery of New Treatments for Lupus Nephritis
- Study Identifies Challenges to Defining Clinical Remission in Juvenile-Onset Lupus
- Researchers Find Possible Risk Sequence Leading to Thrombosis in Lupus
- Compassion, Faith and Helping Others Cope
- Study on Xeljanz Suggests Drug is Helpful for People with Lupus
- New Study Examines Effects of Drivers of Cognitive Dysfunction in People with Lupus
- LFA Becomes First Nonprofit to Fundraise With Cryptocurrency Nodes
- 2019 Lupus Awareness Survey Summary
- Lupus Foundation of America Survey: More than Half of Americans Lack Awareness, Understanding of Lupus
- Survey Shows People with Lupus are Interested in Studies that Examine Diet as a Therapeutic Option
- Cut A. - Diagnosed Age 38
- Teri P. - Diagnosed Age 44
- Kylie G. - Diagnosed Age 18
- Geeves C. - Diagnosed Age 17
- Sunscreen and other measures should be used in people with lupus
- Interleukin-24 Gene Linked to Lupus Disease Activity
- Carotid Ultrasound Assessments Lead to Identification and Reclassification of Cardiovascular Risk in People with Lupus
- Bone Protein Found to Reflect Lupus Disease Activity and Renal Involvement
- Robert M. - Diagnosed Age 26
- Lakita G. - Diagnosed Age 15
- Theresa D. - Diagnosed Age 43
- Study on Acthar Gel Completes Phase 4 Enrollment
- Berniece P. - Diagnosed Age 16
- Samantha S. - Diagnosed Age 18
- In Loving Memory of Myra
- Aleah M. - Diagnosed Age 9
- Zoe P. - Diagnosed Age 15
- Krystyn S. - Diagnosed Age 17
- Kelly T. - Diagnosed Age 36
- Thera H. - Diagnosed Age 19
- Sharing the Journey: Telling Others About Lupus
- Study Confirms Urgent, Unmet Needs in Childhood-Onset Lupus
- House Defense Subcommittee Doubles Funding for Lupus Research Program
- In Loving Memory of Luz
- Maria V. - Diagnosed Age 34
- Study of Renal Tissues Samples and Skin Biopsies Help Approaches to Lupus Nephritis Therapy
- Patti R. - Diagnosed Age 28
- Elizabeth A. - Diagnosed Age 22
- Microbiome Composition Influences Autoantibody Development in Lupus
- Jessica H. - Diagnosed Age 20
- Christina O. - Diagnosed Age 31
- Study Highlights Support Shortfalls for People with Lupus
- Salathiel D. - Diagnosed Age 18
- Update from Finzi Fellows 2018
- Jenny L. - Diagnosed Age 10
- Marilyn K. - Diagnosed Age 21
- Kelly O.- Running to Give Thanks
- Lupus Foundation of America to Ring Closing Bell at Nasdaq to Raise Awareness of Lupus and the Importance of Early and Accurate Diagnosis
- New Research Indicates Retinoblastoma Autoantibodies Protect Against Lupus Nephritis
- Standing Eight Film Brings Lupus to the Big Screen
- Sharing the Journey: June 2019
- Study Shows Gazyva® May Offer Potential New Treatment for Lupus Nephritis
- Mitra G. – Why Connecting with Research is Important
- Priyanka M. - Diagnosed Age 14
- Kayla B. - Diagnosed Age 11
- Stelara Study Shows Promise for Lupus Treatment
- People with Lupus Help Guide Development of the Lupus Foundation of America’s Disease Activity Measure – LFA-REAL
- News to Know from the 20th European Congress of Rheumatology
- Karen S. - Diagnosed Age 40
- Mila D. - Diagnosed Age 22
- Susan W. - Diagnosed Age 40
- Study Reinforces the Importance of Heart Health in Lupus Care
- Sharing the Journey: Advice for Newly Diagnosed
- Low Disease Activity In People with Lupus Results in Lower Healthcare Costs and Other Benefits
- Infertility Episodes May Not Translate to an Inability to Meet Reproductive Goals for African American Women with Lupus
- Certain Factors of Treatment and Disease Activity Can Lead to Serious Infections in People with Lupus
- Gabriella F. - Diagnosed Age 8
- Study Demonstrates Long-term Safety of Belimumab
- Welcome to Research Week!
- Study Shows Care at Dedicated Lupus Clinics may Improve Quality of Life
- Emerging Functional MRI Technology May Help with Early Diagnosis of Lupus
- Promising Genetic Research May Detect Lupus Earlier
- Review of Colombian Patient Registry Reveals Prevalence of Lupus Cases
- Potential Ground-Breaking Trial for Treatment of Lupus Completes Phase 2a
- Summer Interns Learn About Lupus & Further Their Careers
- Federal Agency Grants Award to Fast Track Research of New Lupus Disease Activity Measurement Tests
- Ariane N. - Diagnosed Age 25
- Sarah B. - Diagnosed Age 32
- Lauren Y. - Diagnosed Age 12
- In honor of David L.
- Study Finds Genetic Connection to Hypertension in People with Childhood-Onset Lupus
- Tim M. – Walking With Family Across the U.S.
- Simple Urine Tests May Improve Lupus Nephritis Diagnosis and Monitoring
- Study Examines Link Between Lupus and B Cells’ Genetic Material
- Potential New Treatment for Lupus Begins Trial Phase 1b/2a
- Sharing the Journey: Helpful Resources
- How Can We Help You? Q&A With Lauren Metelski, Rn, Health Education Nurse Manager
- Study Discovers Antibodies Leading to Development of Neuropsychiatric Lupus
- Barry N. - Diagnosed Age 30
- When It Comes to Biologics, Researchers Find Patient Education is Needed
- Emily S. - Diagnosed Age 24
- Benlysta Found to Effectively Change B-cell Levels
- Peripheral Nervous System Disease Proves an Important Part of Lupus-related Nerve Damage
- Investigators Identify Factors and Scoring System to Distinguish Between Central Nervous System Infections and Neuropsychiatric Lupus
- Veronica M. - Diagnosed Age 20
- Fellowship Program Awards Young Scientists, Paves Way for Future Lupus Researchers
- Phase III TULIP 2 Trial of Anifrolumab Demonstrates Meaningful Reduction in Lupus Disease Activity
- The Future of Lupus Research – Supporting Young Scientists
- Janay T. - Diagnosed Age 15
- Periods of Low Disease Activity Improve Outcomes in People with Lupus
- Sharing the Journey: Staying Active
- ALPHA Project: Diversity of Lupus Signs and Symptoms Identified as Major Challenge
- Early Study Findings Signal the Way toward Improved Diagnosis and Treatment of Lupus Nephritis
- Alexis H. - Diagnosed Age 16
- Vitamin D and Bone Health in Lupus: New Study Questions the Effectiveness of Supplementation
- Promising Drug Gazyva® Gets One Step Closer to Approved Use as Lupus Nephritis Treatment
- Trinity B. - Diagnosed Age 13
- Study of Low-dose IL-2 Treatment for Lupus Achieves Significant Remission Rates
- Crystal C. - Diagnosed Age 38
- Significant Rates of Opioid Use for Pain Symptom Management among People with Lupus
- Only Half of People with Lupus Adhere to Hydroxychloroquine (Plaquenil®) Therapy
- Amber D. - Diagnosed Age 17
- A Lupus Bill on Capitol Hill
- Meet the Researcher: Laura Lewandowski
- Study Finds Blood Levels of Plaquenil may be Important Indicator of Eye Disease Risk
- Sharing the Journey: Coping with Lupus’ Mental Health Impact
- Research Studies Validate Superiority of Lupus Test for Clinical Decision-Making and Patient Management
- For People with Lupus, Organ Damage Accrual Comes with Escalating Healthcare Costs Too
- Epiphany T. - Diagnosed Age 23
- Felicia T. - Diagnosed Age 13
- Longer-Term Use of Plaquenil Protects Against Lupus Flares
- Some with Lupus may be Misclassified, Undiagnosed, and Overlooked for Clinical Trials due to Misleading Lab Reports
- SLICC-FI May Predict Future Organ Damage Accrual in People with Lupus
- ALPHA Project: Addressing Top Drug Development Barriers
- New Blood Tests May Support Monitoring – and Ultimately Improve Outcomes – for Kids with Lupus
- Researchers Call for High-Quality Antinuclear Antibody Testing to Improve Lupus Classification and Treatment
- In honor of Wendy W.
- Voclosporin Shows Promise as Potential New Treatment for Lupus Nephritis
- Fatema S. - Diagnosed Age 17
- Tiffany M. - Diagnosed Age 34
- Updates on the latest treatment news from ACR 2019
- Sharing the Journey: Different Experiences
- Debra D. - Diagnosed Age 29
- Rebecca H. - Diagnosed Age 31
- Research Finds Kidney Transplant Successfully Improves Survival Rates in People with Lupus Nephritis
- Stephanie J. - Diagnosed Age 25
- New Study Finds Glucocorticoid Use Contributes to Organ Damage in People with Lupus
- Biogen Announces Positive Phase 2 LILAC Results for New Investigational Drug, BIIB059, for Lupus
- Childhood Abuse May Increase Risk of Lupus in Later Years
- Dr. Emily Von Scheven: Giving young lupus patients the childhood they deserve
- People with Lupus May Focus Most on Fatigue and Pain When Assessing Their Disease Activity
- NFL Stars Take Lupus Awareness to the Football Field
- Sharing the Journey: Health Goals for the New Year
- FDA Grants Fast Track Status to Itolizumab for Lupus Nephritis Treatment
- Children with Lupus Exhibit More Frequent and Severe Cardiac and Vascular Manifestations
- 2019: Unprecedented Year in Lupus Drug Development
- Genetic Risk Scores May Predict Severity and Outcomes in People with Lupus
- Tybrianna W. - Diagnosed Age 18
- Abigail D. - Diagnosed Age 13
- Natalie K. - Diagnosed Age 26
- ALPHA Project: Tackling Lupus Clinical Care Barriers
- Newly Published Results from Anifrolumab’s Phase III Trial Affirm Drug’s Efficacy as Potential Lupus Treatment
- I Suffer From Lupus…
- Levels of Neutrophil Extracellular Traps Can Identify Increased Risk of Disease Activity, Nephritis and Cardiovascular Disease in People with Lupus
- Who is YOUR Lupus Community?
- Phase IIb Trial Results Confirm the Safety and Efficacy of IFN-K, Potential Vaccine for Lupus
- SSPGA and LFA-REAL: New Lupus Measurement Tools Easy to Use and Effective for Clinical Trials
- In honor of Brenda G.
- Monserrath B. - Diagnosed Age 17
- Rebecca Z. - Diagnosed Age 32
- People with Lupus Exhibit Increased Need for Dental Management
- Sharing the Journey: Staying Motivated
- The ALPHA Project: Advancing Lupus Care and Treatment in 2020 and Beyond
- New Findings Alleviate Fears about Pregnancy and Damage Accrual in Women with Lupus
- Finding Peace Through Strength and Endurance
- Shannon C. - Diagnosed Age 50
- Tiffany B. - Diagnosed Age 35
- Lupus May Impair Social Language Skills
- Global Advisory Committee Identifies Priorities to Address Top Challenges in Lupus
- Register Now for the 2020 National Lupus Advocacy Summit
- Universal Kidney Arteriosclerosis Screenings Critically Important for People with Lupus Nephritis
- Statistical Procedure “PCA” Can Characterize Skin Disease Subtypes and Patterns in Cutaneous Lupus Erythematosus
- Eye Health in People with Lupus is Shifting, Some Improvements and New Developments
- New Approach to Cutaneous Lupus Erythematosus Clinical Improvement Measurement May Help Better Understand Response to Treatment and Guide Future Trial Design
- Study Reveals Gaps in Glucocorticoid-Induced Osteoporosis Care Practices in People with Lupus
- Lupus Foundation of America and Lupus Canada Partner to Advance Lupus Research
- How Team Make Your Mark Saved My Life
- LFA Grants to Further Lupus Research – 2020 Grants Open for Applications
- Why should you attend the National Lupus Advocacy Summit?
- Sharing the Journey: Building New Relationships
- Lupus Research on the Cusp of Validating New Biomarkers for the Disease
- Erika M. - Diagnosed Age 34
- Honoring a Best Friend – Carrie and Chole
- Divya R. - Diagnosed Age 25
- Low Dose of Prednisone May be Better than Complete Withdrawal While Lupus is Inactive
- How Holly Fundraises for Lupus Awareness Month
- Buffie Purselle: Using Her Voice and Platform to Raise Awareness
- What the Coronavirus Means for People with Lupus
- Yolanda H. - Diagnosed Age 40
- Lupus Flare Symptoms Associated with Worsened Outcomes and Increased Costs
- International Women’s Day: Celebrating Achievements of Lupus Researchers
- Tracy L. - Diagnosed Age 35
- New Insights Emerge on the Link between Lupus and Stroke
- Research Validates New Blood Pressure Recommendations for People with Lupus
- Sharing the Journey: Managing Brain Fog
- Update on Foundation Events Amid Coronavirus Concerns
- Coronavirus Update: Access to Hydroxychloroquine (Plaquenil) for People with Lupus
- Despite Benefits of Benlysta for People with Lupus, Compliance is Low
- Iguratimod Shows Promise as Potential Therapy for People with Refractory Lupus Nephritis
- LFA Receiving Positive Responses from Key Stakeholders Impacting Hydroxychlorquine Supply during Coronavirus Pandemic
- Global Experts Agree: Hydroxychloroquine (Plaquenil) Must Be Protected for People with Lupus
- Coronavirus Prevention and Underlying Health Conditions Updates
- Are People with Lupus Protected Against COVID-19?
- Medicare to Allow Home Infusions for Benlysta, Other Medications
- New Resources Identified to Access Hydroxychloroquine (Plaquenil)
- Protecting People with Lupus will Help Ensure Best Possible Pandemic Outcomes for All
- Sharing the Journey: Staying Occupied and Reducing Stress During the Coronavirus Pandemic
- Study Identifies Youth and Family Priorities for Childhood Lupus Research
- New Evidence Supports Anti-inflammatory Benefits of Omega-3 Fatty Acids for People with Lupus
- Yvonne R. - Diagnosed Age 27
- Kellye S. - Diagnosed Age 15
- FDA Grants Fast Track Status to Telitacicept for Lupus Treatment
- Mohammed Y. -- Diagnosed Age 31
- Understanding Pain in Lupus
- Study Develops Mental Health Research Agenda for Childhood Rheumatology
- ALPHA Project: Addressing Challenges in Access to Care
- Lupus Foundation of America Leads Nationwide Effort to Make Lupus Visible for Lupus Awareness Month
- COVID-19 and People with Lupus: Risk is Uncertain, and Recommendations are Evolving
- Ora N. - Diagnosed Age 41
- Luciana G. - Diagnosed Age 41
- Karen B. - Diagnosed Age 49
- Advances in Science Identify Cells to Target in Lupus Research and Therapy
- What you can do to protect yourself when your state starts lifting coronavirus (COVID-19) restrictions
- Global Survey Finds Lupus Greatly Impacts Physical Function and Quality of Life
- Maya J. - Diagnosed Age 15
- Early Use of Benlysta Linked to Improved Outcomes in People with Lupus
- Kelli C. - Diagnosed Age 19
- Tanesha R. - Diagnosed Age 14
- Getting You Through the COVID-19 Pandemic
- Sharing the Journey: Talking About Your Invisible Symptoms
- New Members Welcomed to Medical-Scientific Advisory Council
- Amy T. - Diagnosed Age 25
- Exploring the Brain-Immune System Relationship in Neuropsychiatric Lupus
- E'lyse M. - Diagnosed Age 40
- Lower Dosage of Plaquenil Does Not Affect Outcomes and Supports Eye Health in People with Lupus
- Department of Defense Announces 13 New Lupus Research Program Awardees
- Next Step Taken for Potential Lupus Nephritis Treatment, Voclosporin
- In honor of Jessica - Diagnosed Age 24
- Joanna N. - Diagnosed Age 32
- Lauren G. - Diagnosed Age 6
- Sarah W. - Diagnosed Age 12
- Dept. of Defense Announces 2020 Funding Opportunities Through the Lupus Research Program
- New Information on COVID-19 Hospitalization Risk among People with Lupus
- People with Lupus Cite Fatigue and Pain as Their Most Significant Symptoms
- Hydroxychloroquine Has Beneficial Effects on Pregnancy Outcomes in Women with Lupus
- Phase 3 Trial Finds Benlysta Significantly Improves Kidney Response in People with Lupus Nephritis
- Voclosporin Found to be Effective in Both Hispanic/Latino and non-Hispanic/Latino Populations with Lupus Nephritis
- Global Survey Identifies Medication Side Effects and Lack of Effective Treatments as Top Challenges for People with Lupus
- Update: Potential Drug for Systemic Lupus Found Safe and Effective in Phase 2 Trial, Now in Phase 3
- Blood Pressure Levels at Night May Indicate Cardiovascular Risk in Children with Lupus
- Highlights from the 21st European Congress of Rheumatology
- Study Reveals Possible Reason Why Moderate Alcohol Consumption May Lower Lupus Risk
- FDA Revokes EUA For Chloroquine and Hydroxychloroquine
- Study Identifies Ways to Improve Retention among African American Women in Lupus Self-Management Programs
- A Mutation that could Determine People who are at Risk for Lupus Nephritis
- Lupus Foundation of America Survey Finds Over Half of Respondents Experienced Issues Accessing Hydroxychloroquine During Coronavirus Pandemic
- Hydroxychloroquine and Coronavirus Survey Key Findings
- Treatment Patterns Don’t Match Recommendations for People with Lupus Nephritis
- Inpatient Mortality Rates Decrease for People with Lupus
- New Licensing Partnership Spurs Plans for Phase 2 Study of Potential Therapy for Lupus Treatment
- Isha V. - Diagnosed at age 19
- Rafael R. - Diagnosed at age 26
- Kashish J. - Diagnosed at age 13
- Legislation Passed by House Subcommittee Includes Funding for Lupus Research Program
- Study Confirms Association between Lupus and Gum Disease
- Children with Lupus who Transfer to Adult Care are Less Likely to Access Care
- House Committee Advances Funding for Lupus Programs
- COVID-19 Pandemic Widens Disparities Among People with Rheumatic Diseases, Lupus
- Summer Fellowship Grants Support Young Scientists’ Innovative Lupus Research Studies
- Hydroxychloroquine Reduces Low Heartbeat Condition in Newborns
- Sharing the Journey: Self-Care Techniques
- Researchers Identify 8 New Biomarkers which May help Track Disease Activity in Lupus Nephritis
- Exploring the Role of Protein Receptor “Ptprz” in Lupus Nephritis and Future Treatments
- Melissa H. - Diagnosed at age 35
- Lupus Flares Directly Impact Both Quality of Life and Family Life
- Chelsea C. - Diagnosed at age 13
- Tatjana B. - Diagnosed at age 16
- Filing of Application for Lupus Nephritis Treatment Accepted by FDA
- LFA Statement on the Administration's Expected International Pricing Index Model
- Joshua W. - Diagnosed at age 24
- First Study to Assess the Impact of Caffeine on Lupus Disease Activity, Steroid Use, and other Lupus Clinical Measures
- Research Identifies Risk Factors that Predict COVID-19 Hospitalizations among People with Lupus
- New Support Tools Added to Email Series Empowering You to Make Better Decisions on Your Health
- House of Representatives Approves $20.5 Million in Lupus-Specific Funding
- New Data on Lupus Disease Activity and Maternal and Fetal Health Risks during Pregnancy
- Women with Skin Damage Caused by Cutaneous Lupus Report Improved Quality of Life with “Cosmetic Camouflage”
- Phase 2 CALIBRATE Study Indicates Benlysta as Additional Therapy for Lupus Nephritis is Safe
- Sharing the Journey: Unexpected Changes to Your Routine
- Mia P. - Diagnosed at age 24
- ICER to Assess Two Treatments for Lupus Nephritis
- Monique Gore-Massy: A personal journey to Lemonade Maker
- Early Career Scientists Receive Lupus Research Grants Supporting Critical Studies and Growth of Field
- Benefits of Intravenous Cyclophosphamide May Outweigh Mild Risk of Ovarian Dysfunction in Young Women with Severe Lupus
- The Role of Protein “Rab4” in Behavior and Brain Chemistry in People with Neuropsychiatric Lupus
- Older People with Lupus Do Not Have Increased Risk of Flares when Discontinuing Hydroxychloroquine Treatment
- Research Sheds Light on the Seriousness of Involuntary, Illness-Related Weight Loss in Lupus
- Study Finds Drug Costs Keep People with Lupus from Taking Medications as Prescribed
- Japanese Data Show Use of Hydroxychloroquine is Not Associated with Hospitalized Infections
- Study Shows Omega-3 Fatty Acid Supplementation Linked to Reduced Inflammation and Flaring in Lupus
- Nicole M. - Diagnosed at age 30
- Rituximab Shows Promise as Treatment Option for People with Difficult-to-Treat Lupus
- Cutaneous Lupus Impacts Quality of Life in Significant – but Modifiable - Ways
- Walk to End Lupus Now® Goes Virtual, Unites Lupus Community From Coast to Coast
- Bone Hormone Levels May Signal Coronary Artery Disease in People with Lupus
- Hispanic Heritage Month 2020: Healthy Recipes
- Lupus Foundation of America and Lupus Canada Award Grant for Study to Better Predict Pregnancy Outcomes for People with Lupus
- New Test that Indicates Likelihood of Lupus Disease Flares is Now Available
- Vanitha D. - Diagnosed at age 53
- In memory of Judy Ann W. – Diagnosed at age 12
- Bryanna B. - Diagnosed at age 22
- New Study Explores Association Between Diet and Lupus
- Lupus Foundation of America Awarded New Multi-Million Dollar Grant to Increase Lupus Awareness, and Expand Self-management Resources and Services
- Cognitive Dysfunction in Lupus is Prevalent and Not Associated with Disease Activity
- Lupus Nephritis Does Not Appear to Increase Risk of Serious Infection
- Sharing the Journey: Staying Informed on COVID & Safety Measures
- Lupus Foundation of America and American Academy of Family Physicians Collaborate to Help Improve the Diagnosis and Management of Lupus
- New Lupus Drug Investigational Trial Receives National Institutes of Health Grant
- How Trial Lupus Drug Stelara May Work to Reduce Flares
- New Innovative Clinical Trial Launches to Improve Childhood Medication Dosing and Adherence
- Aviana T. - Diagnosed at age 7
- May-Allan S. - Diagnosed at age 18
- Natalie M. - Diagnosed at age 12
- Sharing the Journey: A Good Night’s Sleep
- AVISE Lupus Test Allows for Earlier Disease Diagnosis – and Significant Healthcare Savings
- Shirley J. - Diagnosed at age 30
- Kaylee C. - Diagnosed at age 24
- Kendra R. - Diagnosed at age 11
- Study Further Validates LFA-REAL Disease Activity Measurement Tool for Establishing Lupus Disease Severity
- Intravenous Treatment with Benlysta Slows Organ Damage in People with Lupus
- Quinacrine Shortage
- Several Medications Effectively Reduce Risk of Recurrent Miscarriages in Women with Antiphospholipid Syndrome
- People Critically Ill with COVID-19 and People with Lupus Share Similar Immune-Response Features
- The FDA Has Approved Remdesivir for the Treatment of COVID-19
- Lupus Foundation of America Launches Next-Generation, Patient-Powered Data Platform to Accelerate and Advance Lupus Research
- The Latest Report on APS Treatment Research and Recommendations is Released
- For Children, Having a Blood Disorder by the Time of Lupus Diagnosis May Shape the Course of the Disease
- Native American Heritage Month
- Lupus Foundation of America to Present Findings on Self-Management Resource and Key Global Recommendations Addressing Major Challenges in Lupus at American College of Rheumatology Annual Meeting
- Evelyn Z. - Diagnosed at age 39
- Sharing the Journey: Managing Your Lupus Care
- Hydroxychloroquine Does Not Affect Heart Rhythms in People with Lupus
- Hospitalizations Caused by Cardiovascular Events and Infections Present Serious Health Risks for People with Lupus
- Senate Committee Releases Legislation Including Funding Increases for Lupus Priorities in 2021
- Lupus Research Highlights from ACR's 2020 All-Virtual Annual Meeting
- Carly G. - Diagnosed at age 28
- Metabolic Syndrome in People with Lupus
- Study Shows Cognitive Development is Unaffected in Children Born to Women with Lupus
- Healthcare Professionals Identify Challenges to Providing Care for Children with Lupus
- Christine P. - Diagnosed at age 15
- LFA Statement on Administration’s Most Favored Nation Drug Pricing Rule
- Researchers Reflect Upon Different Lupus Tests Used to Diagnose Lupus
- Lupus Foundation of America Partners with HealthWell to Provide Financial Assistance for Lupus Treatment Costs
- Age at Start of Menstruation and Breastfeeding Duration Linked to Lupus Risk in Black Women
- Team Make Your Mark Virtual 6 Challengers Help End Lupus
- Stay Safe and Stress-Free this Holiday Season
- Sharing the Journey: 2020’s Silver Lining
- NFL Stars Bring Awareness to Lupus During My Cause My Cleats
- Diana Gray to Lead 2021 National Health Council Board of Directors
- Valentina S. - Diagnosed Age 21
- Velika H. - Diagnosed Age 32
- Treatment with Gazyva shows some Advantages over Rituxan
- Meet Barbi, Advocate for Lupus Research
- Gaile V. - Diagnosed at age 56
- Sreshtha S. - Diagnosed at age 33
- Real-World Global Study Affirms Efficacy of Intravenous Treatment with Benlysta for Lupus
- Collaboration and Communication Improve Eye Care for Children Taking Hydroxychloroquine
- Kimberly J. - Diagnosed at age 15
- Lupus Foundation of America Sees Big Win with FDA Approval of Benlysta® for Lupus Nephritis
- Ronda B. - Diagnosed at age 41
- Congress Passes Legislation Providing $21.5 Million in Lupus Funding, Most in U.S. History
- Researching the Role of Sex Hormones in Lupus
- COVID-19 Holiday Guidance As New Year Approaches
- Evaluating Test Scores to Capture Changes in the Brain in People with Lupus
- Study Identifies Molecular Associations with Cognitive Dysfunction in Lupus
- Tara H. - Diagnosed at age 38
- Long-term Treatment with Tacrolimus for Kidney Transplantation in People with Lupus Nephritis is Safe and Effective
- Hydroxychloroquine May Pose Greater Eye-health Risk to People with Lupus Nephritis and Obesity
- Researchers Report Insights to Guide Informed, Equitable and Sustainable Public Health Responses Beyond the COVID-19 Pandemic
- Sharing the Journey: New Year, New Opportunities
- Scientists Advance Lupus Research, Identifying a New and Improved Way to Analyze Electronic Health Records
- Study Offers New Data on COVID-19 and Lupus and Cautions Against Treatment Discontinuation
- Lupus Foundation of America Congratulates Aurinia Pharmaceuticals on FDA Approval of Lupkynis™ (voclosporin) to Treat Lupus Nephritis
- Genes Play a Critical Role in Lupus Disease Outcomes in People from Ghana
- Lupus Advocate Shares Her Advocacy Summit Experience
- Exploring Education Needs Within the Latin-American Lupus Community
- Exploring How Racial and Social Demographics Predict Short-term Lupus Disease Activity
- Journey to Regrowth: Tackling Hair Loss in Black Women
- Physical Inactivity Strongly Tied to Depression in Lupus
- Tricia J. - Diagnosed at age 40
- Mia R. - Diagnosed at age 29
- Leading Lupus Researchers Recognized for Exceptional Work in the Field
- Clock is Ticking – Register Now for the 2021 Digital Lupus Advocacy Summit!
- Narrowing of the Kidneys’ Arteries is Linked to Heart Disease in People with Lupus Nephritis
- Even for People with Mild Lupus, Risk of Cardiac Events and Mortality is Significantly Elevated
- Sharing the Journey: Hair & Skin Issues in Lupus
- Global Experts Lay Out Course to Address Top Barriers in Lupus
- Statement on Passing of Dr. Marc Chevrier, a Lupus Research Pioneer
- Lupus Drug Benlysta Helps Reduce Healthcare Costs Related to Disease Flares
- Panel of Non-Traditional Biomarkers Predicts Serious Heart-Health Risk in Women with Lupus
- New Analysis of Anifrolumab Affirms Drug’s Safety for Lupus Treatment
- Event Resources from Lupus & You: Lupus and the Kidneys
- Asthma and COPD are More Common in Lupus and Tied to Worse Outcomes
- Hydroxychloroquine Treatment is Associated with Longer Duration Breastfeeding in Women with Lupus
- Mortality Rates Significantly Higher Among Hispanic/Latino and Asian People with Lupus
- Testing Positive for Multiple Lupus Autoantibodies is Associated with Lower Breast Cancer Risk
- Cognitive Testing, Reporting and Information in Lupus
- Smoking Exposure Predicts Lupus Skin Disease Issues and Damage
- Lupus is Associated with Increased Risk of Hearing Loss
- Study Underscores Economic Burden of Lupus in America
- Trial of Arsenic Trioxide Finds the Drug is Safe and Effective as a Short-Course Treatment for Lupus
- Amanda M. - Diagnosed at age 19
- Traci J. - Diagnosed at age 25
- Socioeconomic Impact in People with Lupus Skin Disease
- Sharing the Journey: Self-Advocacy Tips
- Women’s History Month: Celebrating Resilient Women in the Lupus Community
- Prednisone Linked to Poor Emotional Health in People with Low Lupus Disease Activity
- Highlights from the 2021 Digital Advocacy Summit
- Total Discontinuation of Prednisone is Achievable in Lupus Remission
- Department of Defense Releases Pre-Announcement of FY 2021 Lupus Research Funding Opportunities
- LFA Shares Impact of COVID-19 Pandemic on People with Lupus During Virtual Congressional Briefing
- The Lupus Foundation of America Stands with the Asian American and Pacific Islander Community
- Hydroxychloroquine Associated with Favorable Cardiac Outcomes in People with Lupus
- Lupus Foundation of America Debuts New, Free Education Series – Lupus & You: Answers. Advocacy. Action
- More Complex Lupus Cases are Associated with Significant Social and Economic Needs
- Fatigue in People with Lupus Experiencing Neuropsychiatric Symptoms Linked to Emotional Health
- Lupus Foundation of America New Three-Year Grant Supports Research to Improve Pregnancy Outcomes in Women with Lupus
- Non-Medication-Based Interventions Improve Mental Health and Quality of Life for People with Lupus
- Tammie H. - Diagnosed at age 29
- Stroke Outcomes in People with Lupus
- Lupkynis Shows Further Efficacy as Treatment for Lupus Nephritis Regardless of Disease Stage
- Study Finds That a Majority of Women With Rheumatic Diseases, Such as Lupus, Want to and Can Breastfeed successfully
- Largest, Most-Racially Diverse Study on Lupus Activity and Survival
- Sharing the Journey: Ways to Manage and Reduce Stress
- Rebekah D. - Diagnosed at age 17
- Hydroxychloroquine Treatment Linked to Healthier Pregnancy in Women with Lupus
- World Lupus Federation Global Survey of People with Lupus Finds Half of Respondents Experienced a Decrease in Access to Healthcare During COVID-19 Pandemic
- People with Lupus Continue to Feel Anxious About Possible Hydroxychloroquine Shortage
- Irmak K. - Diagnosed at age 15
- Dept. of Defense Announces 2021 Funding Opportunities Through the Lupus Research Program
- Department of Defense Announces 10 New Lupus Research Program Awardees
- Lupus Foundation of America Unites Nationwide Lupus Community to Make an Impact for Lupus Awareness Month this May
- In memory of Alicia Botello T. – Diagnosed at age 30
- Candice A.M. - Diagnosed at age 26
- Maurissa, Raising Awareness Every Way She Can
- Lupus Foundation of America Continues Support of CARRA Research Efforts Focused on Childhood-Onset Lupus
- Jordyn W. - Diagnosed at age 18
- Blood Disorders Found to be Common in Children with Lupus
- Lupkynis Continues to Prove Safe and Effective for People with Lupus Nephritis
- LFA Leads Efforts to Provide Patient Voice for Value Assessment of Lupus Nephritis Treatments
- Sharing the Journey: Resilient Lupus Warriors
- Childhood Lupus Study Shows Benefits of Clinical Trials at Home
- Shermya J. - Diagnosed at age 8
- Carolyn B. - Diagnosed at age 35
- Hydroxychloroquine does not increase risk of heart arrhythmias in people with lupus
- Sagree N. - Diagnosed at age 38
- Roychelle H. - Diagnosed at age 21
- Study Finds Mediterranean Diet Beneficial for People with Lupus
- PatientPoint and the Lupus Foundation of America Partner to Bring Lupus Resources to Physician Offices Nationwide
- In honor of Yan-tee E. – Diagnosed at age 21
- Event Resources from Lupus & You: Lupus and the Heart
- Anifrolumab Improves Skin and Joint Disease in People with Lupus
- Rudy Villamar: Conquering the Storm
- Highlights from the 22nd European Congress of Rheumatology
- Improving the Accuracy and Usefulness of the Current Lupus Organ Damage Score Index
- Barbora G. - Diagnosed at age 16
- Sharing the Journey: Sun Protection & Lupus
- Dazlin R. - Diagnosed at age 12
- Victoria M. - Diagnosed at age 46
- People with Lupus Have a Different Makeup of Skin Microorganisms
- Samantha C. - Diagnosed at age 17
- SLE-UPDATE Study Finds Reducing Pain, Fatigue, and Flares are Top Treatment Goals for People with Lupus
- House Subcommittee Advances Legislation Including Funding for Lupus Research Program
- Krystabel D. - Diagnosed at age 23
- People with Lupus Prove to be Resilient during COVID-19 Shelter-in-Place Orders
- Heart Disease Risk Assessment Tools May Fall Short for People with Lupus
- New Research Offers Optimism though Underscores Disparities in Children with Lupus-related Kidney Disease
- Isaiah C. - Diagnosed at age 16
- Healthcare disparities in lupus
- People in Lupus Remission Can Successfully Discontinue Prednisone When Withdrawal is Gradual
- New NIH Research Initiative Supported by LFA Focuses on the Causes of Inflammation and Clinical Disease
- Sharing the Journey: Resources & Tools That Helped You During Your Diagnosis
- House Committee Approves Millions in Lupus Funding
- AVISE Lupus Test Improves Disease Diagnosis and Helps Guide Treatment Decisions
- Hydroxychloroquine is associated with lower risk of developing endometriosis in women with lupus
- Reoccurring and Persistent High Disease Activity in Lupus Linked to Increased Damage Accrual
- Elizabeth B. - Diagnosed at age 11
- Lupus Foundation of America Provides Six Grants to Young Scientists Supporting Important Lupus Research
- In memory of Kaishall A. – Diagnosed at age 11
- Jhanika A. - Diagnosed at age 11
- Why I Participate in the Patient-Powered Research Platform RAY
- COVID-19 Vaccine is Largely Well Tolerated in People with Lupus
- Lupus Clinical Trials Omit Many People from Participating Due to Restrictive Eligibility Criteria
- Roxanne L. - Diagnosed at age 27
- Lupus Foundation of America Celebrates FDA Approval of Saphnelo™ (Anifrolumab-fnia) as a New Treatment for Lupus
- A Combination of Healthy Lifestyle Behaviors is Linked to Reduced Lupus Risk in Women
- Shristi J. - Diagnosed at age 25
- Disease Flares Following COVID-19 Vaccination Found to be Uncommon
- Study Finds Taking Kidney Tissue Samples, Key for Lupus Research, is Safe and Practical
- Lupus Foundation of America and Lupus Canada Award Grant for Study Examining Cognitive Dysfunction in People with Lupus
- Sharing the Journey: Advice for those Newly Diagnosed with Lupus
- For African Americans with Lupus, ‘Lact-Cer’ May Help Predict Heart Disease Beyond Conventional Risk Factors
- Event Resources from Lupus & You: Lupus and the Skin
- Increased Risk of Lupus Associated in People with Post-Traumatic Stress Disorder
- Study Shows Increased COVID-19 Mortality Risk for People with Lupus
- Study Sheds Light on the Physical, Emotional and Economic Burden of Lupus
- Lynnore Thames: Walking to End Lupus
- Several Risk Factors Associated with Oral Lesions in Lupus
- Sharing the Journey: Tips on Sharing Your Lupus with Family and Friends
- Healthcare Costs Rise as Lupus Disease Activity Increases
- Risk Factors for Early Hospital Readmission in Children with New-onset Lupus Nephritis
- Tools for Managing Stress and Thriving This Holiday Season
- Walk to End Lupus Now® Virtual Event Brings Together Lupus Community on October 16
- Irreversible Organ Damage Accrual Linked to Pregnancy Health Risks in Women with Lupus
- Lupus Foundation of America Awards Four Grants to Early Career Scientists, Supporting Crucial Areas of Research and Growth in the Field
- Study Finds Clinical Care is Highly Variable for People with Childhood-onset Lupus
- Lupus-Related Kidney Disease Predicts More Severe Cases of COVID-19
- Study Identifies New Genetic Links to Lupus
- Neuropsychiatric Lupus in Childhood-Onset Lupus is Not Linked to Genetic Risk of Schizophrenia
- Sharing the Journey: How to Navigate Your Emotions
- Wide Differences in Thinking Skills and Abilities Linked to Cognitive Dysfunction in Lupus
- Martin M. - Diagnosed at age 16
- Research Identifies Four Different Lupus Subgroups
- A Night on Broadway
- Lupus Foundation of America to Present Findings on Lupus Self-Management Program, SELF, at American College of Rheumatology Annual Meeting
- Melissa D. - Diagnosed at age 47
- Elevated Quinolinic Acid Relative to Kynurenic Acid Associates with Poor Cognitive Performance in Lupus
- Lupus Research News from ACR’s 2021 Virtual Annual Meeting
- Sharing the Journey: Ensuring Healthy Eating Habits
- New Findings on the Role of Diet and Gut Bacteria in People with Lupus
- Event Resources from Lupus & You: Lupus and the brain
- New Research Shows Top Barriers to Lupus Care and Diagnosis, Including Delayed Access to Specialists and High/Increased Health Care Costs
- Researchers Explore New Ways to Diagnose and Treat Lupus-Related Kidney Disease
- Study Shows Better COVID-19 Outcomes Among Vaccinated People with Rheumatic Diseases, Lupus
- Lupus Foundation of America Statement on the Passing of Former Congresswoman Carrie P. Meek
- Angel Williams Derricott: Overcoming Obstacles and Making a Difference
- Lupus Researchers Receive Prestigious Awards for Distinguished Contributions to the Field
- Long-Term Safety and Efficacy of Trial Lupus Drug Stelara
- Black People with Discoid Lupus Skin Disease Exhibit Increased Skin Damage on Scalp and Ear
- New Drug LUPKYNIS Shows Long-Term Benefits for People with Lupus Nephritis
- My Cause My Cleats Helps NFL Stars Raise Awareness of Lupus
- International Task Force Reaches Consensus on Definition of Lupus Remission
- Air Pollution Shown to Affect Inflammation in Those with Childhood-Onset Lupus
- Sharing the Journey: End of Year Reflection – Lupus Lessons
- Reducing or Stopping Hydroxychloroquine Treatment Associated with Increased Lupus Flare Risk
- Researchers Identify Four Lupus Subgroups Associated with Lupus Outcomes using Long-term Autoantibody Data and Artificial Intelligence
- An Imbalance in Tryptophan Breakdown Products Linked to Poor Cognitive Performance in Lupus
- People with Lupus Report Improved Symptoms with Dietary Changes
- Lupus Foundation of America Awarded $500,000 Grant to Increase Participation of Minority Participants in U.S. Lupus Clinical Trials
- Sharing the Journey: It Takes a Village - Recognizing Your Support System
- Lupus Foundation of America Launches Online Self-Management Program, SELF, to Support People Living with Lupus
- In Pregnant Women with Lupus, Low Blood Levels of Hydroxychloroquine Linked to Preterm Birth
- Hormone Treatment May Help Protect Postmenopausal Women with Lupus against Bone Loss
- Molecular Discoveries in Kidney Biopsies in People with Lupus Nephritis
- Lilly Discontinues Development of Olumiant® for Lupus
- Vitamin D and Fish Oil Supplements for Prevention of Autoimmune Diseases, Like Lupus
- Where To Get Free N95 Masks
- Sharing the Journey: Practicing Self-Care this Valentine’s Day and Every Day
- African American Women with Lupus at Risk of Pregnancy Complications, Even Before Diagnosis
- Stem Cell Therapy Shows Early Promise for the Treatment of Lupus
- New Insights into Long-Term Benlysta Treatment in Lupus
- Peggy P. - Diagnosed at age 13
- Self-Efficacy’s Impact on Pain and Fatigue in Black Women with Lupus
- Encouraging Trial Results for Potential Lupus Drug Iberdomide
- Event Resources from Lupus & You: Vaccines and the Immune System
- In memory of Terrie B. – Diagnosed at age 38
- Study Shows Anxiety is Often an Ongoing Issue for People with Lupus
- New Insights into Antinuclear Antibody Levels in Lupus
- Impaired Growth in Asian Children with Lupus
- International Women’s Day – Celebrating Young Lupus Researchers Making Great Strides in the Field
- A Potential New Frontier in Lupus Treatment Research: Anti-microRNA Therapy
- Research Identifies New Non-Invasive Tests to Screen for and Monitor Lupus
- Congress Set to Approve Millions in Lupus Funding
- Tool Helps Physicians Determine Outcomes and Predict Treatment Response in People with Lupus Nephritis
- Understanding Role of Biomarkers for Lupus Nephritis Treatment Prediction
- Kentucky General Assembly Passes Step Therapy Reform Bill Unanimously
- Risk of Adverse Cardiac Events After Surgery in People with Lupus
- Sharing the Journey: Planning for Pregnancy
- Three Leading Lupus Experts Join LFA Medical-Scientific Advisory Council
- Hydroxychloroquine Decreases Disease Activity in Pregnant Women with Lupus
- Josselyn L. - Diagnosed at age 18
- Lessie J. - Diagnosed at age 14
- Department of Defense Announces 12 New Lupus Research Program Awardees
- Jordana M. - Diagnosed at age 35
- Emmanuel H. - Diagnosed at age 25
- Evidence To-Date Finds Belimumab Safe and Effective for the Treatment of Lupus
- Where a Person Lives May Impact Lupus Disease Activity
- Lupus Linked to Changes in Gut Bacteria
- Multiple ANA Tests May Be Needed to Diagnose Lupus
- Heart Health Management in People with Lupus
- Global Experts Share Priorities for Childhood-Onset Lupus Research and Care
- Ustekinumab Safe and Effective After Two Years in People with Active Lupus
- Study Shows Mindfulness-Based Acceptance and Commitment Therapy Can Benefit People with Lupus
- Certain Biomarkers May Identify Response to Kidney Disease Treatment in People with Lupus Nephritis
- Lupus Foundation of America Honors New York State Assemblyman Fred W. Thiele, Jr. at Lupus Leaders Reception
- Update on the 2022 National Lupus Advocacy Summit
- Department of Defense Releases Pre-Announcement of FY 2022 Lupus Research Funding Opportunities
- People with Childhood-Onset Lupus Benefit from Complementary Treatment Beyond Medication
- Lupus Foundation of America Rallies Communities to Make Lupus Visible for Lupus Awareness Month
- Pregnant Women with Lupus at Higher Risk of Developing Gestational Diabetes
- Study Reveals Links Between Lupus and Heart Disease
- The Importance of Support - Q&A with Asian Community Support Group Leader, Karen Ng
- Strategies People with Lupus Follow to Help Live with the Disease
- Understanding Skin Disease in Lupus
- Dept. of Defense Announces 2022 Funding Opportunities Through the Lupus Research Program
- Video Game-Like Activities Help Improve Mental Functioning in Adults with Lupus
- Phase 3 IRIS Trial of Saphnelo Announced for Lupus Nephritis Treatment
- Potential Lupus Drug Deucravacitinib Moves Onto Phase 3 Clinical Trial
- For People with Lupus, Discontinuing Glucocorticoids May Be Possible
- Shammeer D. - Diagnosed at age 18
- Tammy T. - Diagnosed at age 43
- Risk of Some Pregnancy Complications Remain Unchanged Over Decades for Women with Lupus
- Lisa T. - Diagnosed at age 24
- Elizabeth A. - Diagnosed at age 10
- New Clinical Lupus Test Now Available
- In Males with Childhood-Onset Lupus, Kidney Involvement and Kidney Disease Relapse are Common
- New Blood Test Approved for Lupus Diagnosis
- Reshma R. – Diagnosed at age 29
- Researchers Advocate for More Racially and Ethnically Inclusive Lupus Studies
- Lupus Advocates from Across the Country Make an Impact at Lupus Foundation of America Digital Lupus Advocacy Summit
- Novel Drug Zetomipzomib Yields Encouraging Results in People with Lupus Nephritis
- Millions in Lupus Funding Advanced by House Committee
- New Study Underway Examining How Social Factors May Effect Genes and Lupus Outcomes in African American Women
- Trakela W. – Diagnosed at age 13
- Mohamed S. - Diagnosed at age 10
- Rheumatoid Arthritis Drug Leflunomide Offers Encouraging Results in People with Lupus Nephritis
- Tonia S. – Diagnosed at age 40
- Study Finds COVID-19 Vaccine Booster Beneficial for People with Lupus
- New Mesenchymal Stromal Cell Therapy Shows Promise for People with Difficult-to-Treat Lupus
- Katherine P. – Diagnosed at age 41
- Machine Learning Methods Can Help Predict Lupus Hospitalizations
- Erika R. – Diagnosed at age 34
- Sofia M. – Diagnosed at age 27
- Breaking News: FDA Approves Benlysta for Children with Lupus Nephritis
- Reina R. – Diagnosed at age 16
- Lupus Foundation of America Summer Fellowship Program Awards Grants to Six Young Scientists
- Study Finds mRNA COVID-19 Vaccine and One Booster Dose May Not Fully Protect against Breakthrough Case of Omicron Variant in People with Autoimmune Disease
- Population-based research study shows increase in lupus disease rates
- Further Positive Results on Drug Therapy Litifilimab (BIIB059) for Treatment of Cutaneous Lupus Erythematosus
- Improving Hydroxychloroquine Adherence through Patient- and Provider-Informed Interventions
- Research Reveals Unique Sub-Groups of Type 2 Lupus
- CDC's Updated COVID-19 Guidelines
- Michele M. – Diagnosed at age 35
- Multiple Definitions of Lupus Remission and Low Disease Activity Linked to Less Damage
- Bolanle I. – Diagnosed at age 33
- Desirae M. – Diagnosed at age 25
- Bettina L. – Diagnosed at age 25
- Researchers Develop New Scoring System to Measure Lupus Outcomes
- Dawn R. – Diagnosed at age 32
- Vania N. – Diagnosed at age 17
- Interleukin-2 Based Therapy Shows Promise in People with Moderate-to-Severe Lupus
- Edie B. – Diagnosed at age 55
- Disparities in Asian and Hispanic Lupus Populations Following Diagnosis
- Lupus Foundation of America and Lupus Canada Award Grant for Critical Study Examining Platelet Biology as a Potential Lupus Treatment Pathway
- Women with Lupus Nephritis at Higher Risk of Pregnancy Complications
- Walk to End Lupus Now® Brings Communities Together to Help End Lupus
- MOONLIGHT Study Will Assess Effectiveness of Belimumab for People of Asian Ethnicity with Lupus Nephritis
- Hydroxychloroquine is Not Associated with Increased Risk of Arrhythmia in People with Lupus and Rheumatoid Arthritis
- Study Finds Lupus Nephritis Care and Treatment Varies in Children and Teens
- Results From Promising New Therapy Shows it May Drive Lupus into Remission
- Newer Lupus Classification Criteria Outperform Older Criteria
- New Drug Trial Finds Ustekinumab May Not Be Effective for Treatment of Lupus
- Lack of Sleep Linked to Increased Risk of Developing Lupus Among Women
- Machine Learning Can Be Used to Improve the Ability to Predict Adverse Pregnancy Outcomes in Women with Lupus
- Encouraging Drug Treatment Results Announced from the EQUALISE Study in People with Lupus Nephritis
- New Findings Show No Association Found Between COVID-19 Vaccination and Lupus Flares
- Study Finds Factors that Contribute to Medication Nonadherence Among People with Lupus
- New Evidence Continues to Support Lupus Drug Belimumab’s Safety Profile
- Impact of Belimumab Exposure on Pregnancy Outcomes in Women with Lupus
- Researchers Identify Potential Biomarker to Support Lupus Diagnosis and Treatment Planning
- Disease Flare Activity in People with Lupus Nephritis on Dialysis
- Melissa Osoria: I Went in Fierce and Came Out Resilient
- Tashay R. – Diagnosed at age 30
- Alisa S. – Diagnosed at age 35
- First Person Receives Dose of Drug Therapy Litifilimab (BIIB059) for Treatment of Cutaneous Lupus Erythematosus
- Black and Hispanic Americans with Lupus Experienced More Severe COVID-19 Outcomes
- In Minnesota, Rates of Lupus Nephritis and Poor Health Outcomes Highlight Need for Advancements in Lupus Research and Care
- Traci L. – Diagnosed at age 14
- Study Finds New Predictor of Treatment Response for People with Lupus Nephritis
- Lupus Foundation of America Research Initiatives to be Presented at the 2022 American College of Rheumatology Annual Meeting
- Lupus Foundation of America Recognizes Scientists for Exceptional Contributions in Lupus Research
- Lupus Foundation of America Awards Four Grants Supporting Early Career Scientists, Funding Critical Areas of Research
- New Investigational Drug for Lupus Nephritis Receives Phase 1 Clearance from FDA
- Lupus Research News from ACR’s 2022 Scientific Meeting
- CDC Awards More Than $4 Million To Support Childhood Lupus Research
- New Study Finds Belimumab Improves Cutaneous Lupus After At Least 20 Weeks of Use
- Health Literacy Linked to Trust in Physicians Among People with Lupus
- Researchers Validate New Biomarker for Lupus Nephritis
- Biologic Therapy, Telitacicept, Found to be Effective and Safe Potential Treatment Option for Lupus
- NFL Players Raise Awareness For Lupus During My Cause My Cleats Campaign
- In Memory of Catherine - Diagnosed at age 45
- Study Shows Cutaneous Lupus May Have A Genetic Component, Especially Among Black People with Lupus
- Sharing Your Experiences with Lupus May Improve Quality of Life
- Joeie P. - Diagnosed at age 39
- Rituximab Shows Promise as Effective Therapy Option for Lupus Nephritis
- Senate Approves Millions in Lupus Funding
- Phase 3 Trial of Cenerimod Announced for Lupus Treatment
- Talina M. - Diagnosed at age 11
- Jackie L. - Diagnosed at age 19
- Healthcare Costs Higher for People with Lupus Nephritis
- Vitamin D Status a Common Health Concern for People with Lupus, Though Not Linked to Disease Activity
- Cardiovascular Disease Incidence and Disparities in People with Lupus
- Understanding Ancestry’s Role in Lupus Disease Risk, Severity, and Response to Treatment
- In Memory of Sadie - Diagnosed at age 23
- New Investigational Drug for Systemic and Cutaneous Lupus Advancing to Phase I Clinical Trials
- Amenna S. - Diagnosed at age 6
- Makayla H. - Diagnosed at age 19
- Rosemary G. - Diagnosed at age 32
- Lupus Advocates Lead the Way in 2022
- Scott S. - Diagnosed at age 45
- Anifrolumab (SAPHNELO®) Associated with Low Lupus Disease Activity
- Global Experts Report a Lupus Spectrum Definition May be Needed to Improve Outcomes in People Living with the Disease
- Curtisha Anderson: Becoming Her Own Best Advocate
- New Study Showcases Key Differences Between Males and Females with Lupus
- LUPKYNIS Will Continue to Be Refined for Improved Lupus Nephritis Treatment
- New Study Finds Fertility Treatments to be Safe and Effective in Women with Lupus
- COVID-19 Vaccine Response and Management in People with Lupus
- Britty M. - Diagnosed at age 14
- Cognitive Function Found to Be Largely Stable Over Time in Adults with Lupus
- New Lupus Nephritis Test Under Development: The Non-invasive System Uses a Smartphone App to Monitor Disease Activity
- Global Lupus Experts Recommend Changes to Clinical Trial Outcome Measures to Expedite Development of Therapeutics
- Honoring the Strength and Perseverance of Darline
- Mariah P. - Diagnosed at age 23
- Katherine C. - Diagnosed at age 33
- Bie N. - Diagnosed at age 37
- Amina K. - Diagnosed at age 14
- New Study Found People with Lupus Have Unique Oral Bacteria
- Alejandra A. - Diagnosed at age 19
- Jeanette Alston-Watkins: A Voice to be Heard
- Celebrating Women's History Month 2023
- Ruby K. - Diagnosed at age 23
- 12 New Lupus Research Program Awards Announced by Dept. of Defense
- In Memory of Sondos M. - Diagnosed at age 14
- Organ Damage Associated with Worse Cognitive Performance in People with Lupus
- Livestreaming to Make Lupus Visible
- Natasha W. - Diagnosed at age 16
- 10 Reasons to Attend the National Lupus Advocacy Summit
- Jules A. - Diagnosed at age 14
- New Study Examines Lung Function in Children with Lupus
- Monay S. - Diagnosed at age 39
- RINVOQ Advances to Phase 3 Clinical Trials for Lupus Treatment
- Belimumab is Safe and Effective in Older Adults with Lupus
- Socioeconomic Factors and Hospitalizations in Children with Lupus
- Color Street Foundation Raises Awareness of Lupus During Autoimmune Disease Awareness Month
- Crystal F. - Diagnosed at age 37
- In People with Lupus, Age and Location Linked to Delayed Follow-Up After Hospitalization
- Social Factors Impact Those with Lupus
- Addressing the Impact, Development and Treatment of Lupus in Low- to Middle-Income Countries
- Lupus Treatment and Infection Risk Management
- Kicking Lupus to the Curb: Mackenzie's Make Your Mark Fundraiser
- Karen P. - Diagnosed at age 24
- Brittany E. - Diagnosed at age 18
- Study Validates LFA-REAL Disease Activity Measurement Tool for Lupus Disease Severity Measurement
- Study Examines Connection Between Diet and Lupus Progression
- LUPKYNIS Continues to Show Promising Lupus Nephritis Outcomes
- Department of Defense Releases Pre-Announcement of FY 2023 Lupus Research Funding Opportunities
- Clinical Trial for New Lupus Treatment Opens in China
- The Lupus Sisters: Walking for a Cure
- Lupus Advocates from Across the Country Return to Capitol Hill, Urge Congress to Support Policies that Improve Access to Lupus Care
- Toni Braxton Opens Up About Her Lupus Complications Ahead of Lupus Awareness Month
- Lupus Foundation of America Brings Together Communities to Make Lupus Visible for Lupus Awareness Month
- Missing Data Leads to Misrepresentation and Impacts Health Disparities in Children with Lupus
- Does Better Clinical Care Promote Higher Quality of Life for Those with Lupus?
- Francesca R. - Diagnosed at age 23
- Vanessa W. - Diagnosed at age 67
- Hassie S. - Diagnosed at age 57
- FDA Grants Fast Track Status to Investigational Therapy CABA-201 for Lupus Treatment
- Study on Daxdilimab for Treatment of Lupus Nephritis Enrolls First Patient
- Dept. of Defense Announces Lupus Research Program's 2023 Funding Opportunities
- Emily T. - Diagnosed at age 14
- Priya P. - Diagnosed at age 33
- Catherine H. - Diagnosed at age 22
- Researchers Found belimumab and anifrolumab to be Comparable Treatment Options for Lupus
- Study Finds Four Predictive Lupus Disease Profiles Using Machine Learning
- Researchers Identify New Biomarker Which May Help Treat Lupus Nephritis
- New Study Examines Preconception Planning Benefits for Women with Lupus
- Lupus Awareness Campaign Empowers Black/African American and Hispanic/Latina Women to Stop Ignoring Symptoms That Could Be Lupus-Related
- Igniting Awareness: Lupus Warriors Illuminate Monuments for World Lupus Day
- Determinants of Neuropsychiatric Flares in People with Lupus
- Researchers Found Adding Antimalarial Drugs to Belimumab Enhances Protection Against Renal Flares
- RINVOQ Continues to Show Promise for Lupus Treatment
- Tracey L. - Diagnosed at age 38
- Patricia A. - Diagnosed at age 32
- RaeShem H. - Diagnosed at age 26
- Belly M. - Diagnosed at age 23
- LUPKYNIS® Continues to Show Favorable Outcomes for Lupus Nephritis Treatment
- UPDATED: First Participant Enrolled in KYV-101 Clinical Trial for Refractory Lupus Nephritis Treatment
- Colorado, Texas Pass Legislation to Limit the Use of Copay Accumulators
- Government Officials Around the Country Issue Lupus Awareness Month Proclamations
- Sharan S. - Diagnosed at age 14
- Investigational Drug, Rituximab Biosimilar BCD020, Shows Promise for Treatment of Pediatric Lupus Nephritis
- House Committee Advances Millions in Funding for Lupus Research Program
- Elevating the Male Lupus Voice During Men's Health Month
- Melany T. - Diagnosed at age 19
- New Study Identifies Certain Gut Bacteria as Potential Drivers of Lupus Flares
- Lupus Foundation of America Announces Joseph Arnold as New Board Chair for its National Board of Directors
- Administration of New Oral Treatment for Lupus Begins in Phase 2B Study
- Mary C. - Diagnosed at age 42
- Melissa D. - Diagnosed at age 8
- Renita H. - Diagnosed at age 32
- Nicole E. - Diagnosed at age 22
- Long-Term Voclosporin Treatment for Lupus Nephritis Found Safe and Effective
- Yani K. - Diagnosed at age 39
- International Taskforce Proposes Structure for Improving Lupus Clinical Trials
- Study on Daxdilimab for SLE Treatment Misses Primary Endpoint
- I'Dallys E. - Diagnosed at age 13
- New Study Found People with Autoimmune Diseases Underreport their Mental Health Status
- Senate Committee Advances Legislation Including Lupus Funding
- Lupus Foundation of America Awards Five Summer Fellowship Grants to Young Scientists, Supporting Growth of Lupus Research Field
- New Lupus Foundation of America Research Identifies Barriers to Health Equity for Minorities with Lupus
- Walking the Path of Lupus Awareness: A Tribute to Mario's Legacy
- New Study Examines Relationship Between Vitamin D Levels and Bone Density in People with Lupus
- Study Explores Remote Assessment Feasibility in Lupus Research
- Racial Discrimination Linked to Inflammation in Black Women with Lupus
- FDA Approves Clinical Trial of New Therapy for Refractory Lupus
- Marcia L. - Diagnosed at age 14
- Lupus Foundation of America and Lupus Canada Award Grant for Study Examining New Method to Predict Treatment Response in Lupus Nephritis to Improve Kidney Outcomes
- New Study Suggests Better Management of Cardiac Events is Needed in People with Lupus
- Anifrolumab (SAPHNELO®) Added to Standard Therapy May be Safe Option for Active Lupus Nephritis Treatment
- New Investigational Therapy for Lupus Treatment, GLPG3667, Begins Phase 2 Study
- Study Suggests Exercise May Be a Powerful Therapy for Lupus
- Analysis Finds Certain Rheumatic Diseases, Like Lupus, Disproportionately Affect People of Color
- Walk to End Lupus Now® Unites Communities to Take Steps in the Fight Against Lupus
- Making His Miles Matter: Nathan's Marathon for Lupus Awareness
- New Collaboration Aims to Advance Cell Therapy for Autoimmune Diseases Like Lupus
- Health-Related Quality of Life in People with Lupus with High Cardiovascular Risk
- Update: KYV-101 for Treatment of Refractory Lupus Nephritis Appears Safe for First U.S. study participant After 28-Days of Dosing in Phase 1 Study
- Lupus Foundation of America Launches Mobile App for Lupus Self-Management Program
- SELF is Now a Mobile App!
- $3 Million Grant Awarded to Develop Artificial Intelligence to Help Diagnose Lupus Nephritis
- Increasing Resources to Spanish-Speakers with 12-week Email Series Tome Control
- Predictors for the Development of Systemic Lupus Erythematosus in People with Sjogren’s Syndrome
- New Study Examines the Benefits of Ginger Supplements in Autoimmune Diseases Like Lupus
- Experimental Treatment, Zetomipzomib, for Lupus Nephritis to be Developed and Marketed in Asia
- Supplementation of Mycophenolate with Belimumab Shows Promise in Treatment of Lupus Nephritis
- Asha N. - Diagnosed at age 12
- Quenetta W. - Diagnosed at age 30
- Janet M. - Diagnosed at age 40
- Debra B. - Diagnosed at age 24
- Ndumiso N. - Diagnosed at age 17
- Predicting Cardiovascular Disease using Biomarkers in Young People with Juvenile-Onset Systemic Lupus Erythematosus
- Celebrating Hispanic Heritage Month: Understanding Lupus and Its Unique Impact on the Hispanic Community
- Increasing Use of Biologics in the Treatment of Systemic Lupus Erythematosus
- FDA Grants Fast Track Status to Investigational Therapy IMPT-514 for Treatment of Both Active Refractory Lupus Nephritis and Systemic Lupus Erythematosus
- Anabel R. - Diagnosed at age 39
- Zunaira M. - Diagnosed at age 18
- 2023 Updates to EULAR Recommendations for Management of Systemic Lupus Erythematosus
- Ivey M. - Diagnosed at age 32
- Taxifolin Supplements Demonstrate Protective Effects Against Lupus and Antiphospholipid Syndrome
- Machine Learning Can Help Predict Length of Hospital Stay for Lupus Flares
- New Investigational Drug for Lupus Nephritis Receives Clearance from FDA for Clinical Trial Evaluation
- Higher Copayment Associated with Lower Medication Adherence in People with Systemic Lupus Erythematosus
- New Study Explores the Relationship between Subclinical Atherosclerosis and Retinal Vascular Impairment in People with Systemic Lupus Erythematosus
- Fabiana M. - Diagnosed at age 44
- Tischa C. - Diagnosed at age 43
- Natalie W. - Diagnosed at age 35
- Briah C. - Diagnosed at age 17
- Using Electronic Health Record Data to Identify and Assess Algorithms for Detecting Features of Systemic Lupus Erythematosus
- Researchers Identify Potential Biomarker for Active Lupus Nephritis Found in Non-lesional Skin
- Lupus Foundation of America Awards Grants to Two Early Career Scientists, Funding Studies in Pregnancy and Personalized Medicine
- Impact of Inflammation in Developing Central Nervous System of Children with Lupus
- Alicia H. - Diagnosed at age 23
- Sherria L. - Diagnosed at age 30
- Lupus Foundation of America Research Accomplishments to be Presented at the 2023 American College of Rheumatology Annual Meeting
- Study Finds Link Between Omega 3 and Omega 6 Fatty Acid Consumption in Women with Systemic Lupus Erythematosus
- Lupus Foundation of America Awards Scientists for Notable Contributions to Lupus Research
- Game On! To End Lupus at TwitchCon 2023
- Latest Discoveries in Lupus Research Highlighted at ACR’s 2023 Scientific Meeting
- In Combination with Standard Therapy, Obinutuzumab Demonstrates Kidney Function Preservation and Flare Prevention in People with Lupus Nephritis
- Lupus Foundation of America Awards Four Grants to Support and Advance Childhood Lupus Research
- Jade T. - Diagnosed at age 18
- Phase 2 Study of Oral Brepocitinib for Systemic Lupus Erythematosus Fails
- Comparison of Tests for Systemic Lupus Erythematosus Diagnosis and Disease Monitoring
- Outcomes of Emergency Department Visits in People with Systemic Lupus Erythematosus
- Telitacicept Found to Be a Safe and Effective Lupus Treatment
- NFL Players Shine a Spotlight on Lupus for the My Cause My Cleats Campaign
- Pregnancy Planning and Management Intervention for Women with Systemic Lupus Erythematosus
- New Drug Application for LUPKYNIS® Filed in Japan for Lupus Nephritis Treatment
- Kidney Transplantation Evaluation and Referral in People with Lupus Nephritis-Related End-Stage Kidney Disease
- Interviewing Black Adults with Systemic Lupus Erythematosus to Improve Engagement and Inclusion in Lupus Research
- New Investigational Drug for Refractory Systemic Lupus Erythematosus Receives Clearance of IND Application for Phase 1/2 Clinical Trials from FDA
- Lupus Disease Activity and Organ Damage Varies by Socioeconomic Status in Black Women
- FDA Approves Phase 1 Trial of CNTY-101 for People with Systemic Lupus Erythematosus
- New Lupus Nephritis Educational Video Series from the National Kidney Foundation
- New Assessment for Type 2 Systemic Lupus Erythematosus Symptoms
- Lupus Foundation of America Awarded Grant to Continue to Increase Black/African American Participation in U.S. Lupus Clinical Trials
- Make Your Miles Matter in 2024: Run, Walk, or Bike in the Fight Against Lupus
- Summer D. - Diagnosed at age 42
- Shadé M. - Diagnosed at age 34
- Lupus Foundation of America Statement on the Passing of Former Congresswoman Eddie Bernice Johnson
- Lupus Foundation of America Announces Two New Members to its National Board of Directors
- Relationship between Systemic Lupus Erythematosus and Primary Biliary Cirrhosis
- Spiritual Interventions for Improving Psychological Symptoms in People with Systemic Lupus Erythematosus
- Drug Update: First Person Dosed with Investigational Drug, VENT-03, for Lupus
- The Role of Interferon Gene Signature in Systemic Lupus Erythematosus
- Eye Changes in People with Systemic Lupus Erythematosus as a Potential Biomarker
- Use of Non-invasive Machine Learning to Help Predict the Chronic Degree of Lupus Nephritis
- Predicting Systemic Lupus Erythematosus Using a Clinical Algorithm Model and Cell DNA
- New Potential Predictive Biomarker for Lupus Nephritis
- Nadine Kidd's Lupus Journey: Navigating Discrimination and a Path to Healing
- New Study Examines Predictors of Renal Flares in People with Systemic Lupus Erythematosus Treated with Belimumab
- Health Insurance Status Associated with Long-Term Lupus Nephritis and Systemic Lupus Erythematosus Outcomes
- New Study Finds Possible Linkage to Autoimmune Prevalence in Women
- Telitacicept Could Be a Potential Treatment for Lupus Hepatitis
- Stephanie F. - Diagnosed at age 39
- Shaniyah W. - Diagnosed at age 15
- Re-Engineered Immune Cells Could Offer a Potential Treatment for People with Lupus Nephritis & Other Autoimmune Diseases
- Tacrolimus Found to be an Effective Long-Term Treatment for Lupus Nephritis in Japan
- Prevalence of Celiac Disease in People with Systemic Lupus Erythematosus
- CAR-T Cell Therapy Shows Promising Results for People with Lupus and Other Autoimmune Diseases
- First Person Treated for Severe Systemic Lupus Erythematosus Using CAR-T Cell Therapy, CC-97540
- Investigational Therapy AlloNK Receives FDA Fast Track Status for Lupus Nephritis Treatment
- Investigational New Drug Application for ATA3219 Submitted to the FDA for Lupus Nephritis Treatment
- Potential New Biomarker for Systemic Lupus Erythematosus
- Yashica W. - Diagnosed at age 17
- Suzanne M. - Diagnosed at age 77
- Psychological Well-Being Associated with Quality of Life in People with Systemic Lupus Erythematosus
- Application of Machine Learning in Lupus Research Advancement
- UPDATE: Investigational New Drug, ATA3219, Receives FDA Approval for Lupus Nephritis Treatment Study
- Study Identifies Two Potential Biomarkers for Active Systemic Lupus Erythematosus Disease Activity
- Alishba G. - Diagnosed at age 18
- FDA Authorizes First CAR-T Cell Clinical Trial for Children with Lupus
- Certain Antibodies Linked to Systemic Lupus Erythematosus-Related Thrombocytopenia Disease May Increase Disease Severity and Outcomes
- UPDATE: Recruitment Underway for Investigational Therapy IMPT-514 for Treatment of Both Active Refractory Lupus Nephritis and Systemic Lupus Erythematosus
- FDA Approves Supplemental New Drug Application (sNDA) for the Acthar® Gel SelfJect™ Injector for Treatment of Autoimmune Conditions
- Honoring Beryl: A Tribute to Love and Resilience
- Congress Set to Approve Millions in Lupus Funding
- Aarti D. - Diagnosed at age 14
- Shawnelle M. - Diagnosed at age 21
- Researchers Identify Potential New Genetic Biomarker for Systemic Lupus Erythematosus
- New Blood Test Poised to Revolutionize Care for Systemic Lupus Erythematosus
- What to Expect at the National Lupus Advocacy Summit
- Karleen's Journey: Navigating Life with Lupus
- Drug Update: Itolizumab for Treatment of Lupus Nephritis Improves Kidney Biomarker Levels
- Racial Differences Found in the Microbiome in People with Systemic Lupus Erythematosus
- International Task Force Issues Physical Activity and Exercise Recommendations for People with Systemic Lupus Erythematosus
- Researchers Discover Potential New Target for Lupus Nephritis Treatment
- FDA Approves a Phase 1 Trial for Investigational Therapy, CB-010, for Lupus Nephritis Treatment
- Potential New Diagnostic and Disease Monitoring Biomarker for Systemic Lupus Erythematosus Found in B Cells
- Study Examines Cognitive Performance Measurement Tools in People with Systemic Lupus Erythematosus
- Drug Update: First Person Dosed with Investigational Therapy AlloNK for Lupus Nephritis
- Neighborhood Disadvantage Associated with Lower Testing and Physician Access in Young People with Systemic Lupus Erythematosus Despite Insurance Coverage
- Study Reveals Depression is Often Undiagnosed in People with Systemic Lupus Erythematosus
- Differences in Disease Activity by Onset-Age in People with Systemic Lupus Erythematosus
- World Lupus Federation Global Survey Finds 91% of People with Lupus Report Using Oral Steroids to Treat Lupus
- FDA Approves Benlysta Autoinjector for Treatment of Children with Systemic Lupus Erythematosus
- Lupus Advocates Rally on Capitol Hill to Champion Lupus Care Access During Lupus Awareness Month
- Lupus Foundation of America Awards Grants to Six Young Scientists Contributing to Lupus Research
- In Vitro Fertilization Treatment in Women with Systemic Lupus Erythematosus
- The Role of Genetic Variations and Molecular Signature in Active and Inactive Systemic Lupus Erythematosus
- iTRAQ Technology Identifies Potential New Biomarkers for Systemic Lupus Erythematosus
- Hydroxychloroquine Dose and Hospitalization Risk in People with Systemic Lupus Erythematosus
- Safety and Efficacy of LUPKYNIS® for Lupus Nephritis Treatment to be Presented at EULAR 2024
- Health Literacy Associated with Medication Adherence and Quality of Life Among Individuals with Childhood-Onset Systemic Lupus Erythematosus
- Decision Aids Improve Patient-Centered Care for People with Systemic Lupus Erythematosus
- Hydroxychloroquine Levels in Women with Systemic Lupus Erythematosus Associated with Flare Activity but Not with Adverse Pregnancy Outcomes
- Pabrita B. - Diagnosed at age 18
- RAY Users Speak on the Importance of Participating in Lupus Research
- Systemic Lupus Erythematosus Genetics Not Associated with Neonatal Lupus Outcomes
- Update: Investigational Therapy CABA-201 for Lupus Treatment Shows Positive Initial Data
- Angel J. - Diagnosed at age 43
- Elizabeth L. - Diagnosed at age 5
- Ronida K. - Diagnosed at age 25
- Lupus Foundation of America Appoints Louise Vetter as President and Chief Executive Officer
- House of Representatives Approves Funding for the Lupus Research Program at the Department of Defense
- Investigational Therapy NKX019 for Lupus Nephritis Treatment Begins Screening Trial Participants
- Britty M. - Diagnosed at age 14
- Madeline W. - Diagnosed at age 19
- Windy T. - Diagnosed at age 30
- Quantavia G. - Diagnosed at age 31
- Adina F. - Diagnosed at age 28
- Angela M. - Diagnosed at age 40
- Kashish J. - Diagnosed at age 13
- House Committee Votes to Nearly Double Lupus Research and Education Funding
- New Research Finds Cells May Cause Systemic Lupus Erythematosus and Possible Approach for Disease Reversal
- High Intake of Ultra-Processed Foods Associated with Increased Risk of Systemic Lupus Erythematosus
- Jessica B. - Diagnosed at age 23
- Joyce A. - Diagnosed at age 17
- Sofia G. - Diagnosed at age 20
- Study Finds Certain Autoantibodies May Serve as Biomarkers for Lupus Nephritis
- First Person Dosed with Descartes-08 for Treatment of Systemic Lupus Erythematosus
- Manali S. - Diagnosed at age 60
- Alana W. - Diagnosed at age 28
- Eric R. - Diagnosed at age 7
- Study Finds Krill Oil Concentrate Could Replenish Omega-3 Levels and Decrease Systemic Lupus Erythematosus Disease Activity
- Genetic Predisposition and Long-Term Exposure to Air Pollution Associated with Increased Risk of Developing Systemic Lupus Erythematosus
- Lupus Foundation of America Supports the Advancement of Childhood Lupus Research Through Two Pediatric Lupus Grants
- Ari A. - Diagnosed at age 18
- Study Finds Diagnostic Bias May Contribute to Misdiagnosis, Missed Diagnosis and Delayed Diagnosis of Systemic Lupus Erythematosus Among Men
- Lupus Foundation of America and Lupus Canada Award Research Grant Aiming to Reduce Shingles Risk for People with Lupus
- Study Examines How Social Determinants Influence Cardiovascular Risk for People with Systemic Lupus Erythematosus
- Immunosuppressant Treatment Response in People with Systemic Lupus Erythematosus
- Shared Decision-Making in Systemic Lupus Erythematosus Management Associated with Increased Physician Trust
- Celebrate National Make-a-Will Month by Creating a Legacy
- Challenges and opportunities in CAR-T Cell Therapy Treatment in Autoimmune Diseases like Lupus
- New Biomarker Identifies Link Between Allergic Rhinitis and Systemic Lupus Erythematosus
- Finding Hope in the Walk to End Lupus Now
- Anti-Smith Antibodies Associated with Increased Risk of the Development of Lupus Nephritis, but Not a Stand-alone Predictive Biomarker
- Conduit Pharmaceuticals Announces Phase 2a Clinical Trial of AZD1656 for Treating Multiple Autoimmune Diseases, Including Lupus
- Tamara C. - Diagnosed at age 47
- Daniela D. - Diagnosed at age 17
- Brenna V. - Diagnosed at age 45
- Limited Health Literacy Associated with Worse Systemic Lupus Erythematosus Outcomes
- CAR T Cell Therapy May Help to Induce Depletion of B Cells in Deep Tissue of People with Autoimmune Diseases
- Advanced Neuroimaging Helps Identify Brain Abnormalities Associated with Cognitive Dysfunction in People with System Lupus Erythematosus
- Lupus Foundation of America Supports Four Early Career Scientists Advancing Lupus Research
- Caitlyn E. - Diagnosed at age 23
- Walk to End Lupus Now® Brings Communities Together Nationwide in the Fight Against Lupus
- Australian Biotech Company, Naxopharm Limited, Announces its First In-Human Study of Investigational Treatment, SOF-SKN, for Cutaneous Lupus
- New Research Explores Efficacy of Belimumab and Rituximab Combination Therapy for Systemic Lupus Erythematosus
- Kacey C. - Diagnosed at age 17
- Precious B. - Diagnosed at age 50
- Memory C. - Diagnosed at age 22
- Daniela G. - Diagnosed at age 15
- Jami T. - Diagnosed at age 15
- Quatasia C. - Diagnosed at age 29
- Nicole L. Diagnosed at age 57
- Central Retinal Artery Occlusion as a Potential Indicator for Systemic Lupus Erythematosus
- Hydroxychloroquine Monitoring Associated with Lower Hospital Visits in People with Lupus
- Exploring Autoimmune Prevalence and X Chromosome Inactivation in Systemic Lupus Erythematosus
- Use of Hydroxychloroquine May Provide Protection Against Cardiovascular Events in People with Systemic Lupus Erythematosus
- Cardiovascular Disease Event Prevalence Higher Among People with Systemic Lupus Erythematosus
- Cullinan Therapeutics Files Investigational New Drug Application with FDA for CLN-978 for Treatment of Systemic Lupus Erythematosus
- UCB and Biogen Announce Positive Phase III Clinical Trial Results for Dapirolizumab Pegol for Treatment of Systemic Lupus Erythematosus
- Celebrating Hispanic Heritage Month 2024: Addressing Lupus in the Hispanic Community
- Study Finds Systemic Lupus Erythematosus and Inflammatory Bowel Disease Share a Common Set of Microbiome Characteristics
- UPDATE: Positive Phase III Clinical Trial Results Announced for Gazyva for the Treatment of Lupus Nephritis
- New Information for the Medicare Part D Open Enrollment
- Race and Social Determinants of Health Influence Low Lupus Disease Activity in Children with Childhood-Onset Systemic Lupus Erythematosus
- Delia Q. - Diagnosed at age 16
- Sayeka K. - Diagnosed at age 18
- UPDATE: FDA Places Kezar Life Sciences’ Phase 2b Study of Zetomipzomib for Lupus Nephritis Treatment on Clinical Hold
- Review of Neuropsychiatric Lupus Diagnosis and Management
- Cheyenne W. - Diagnosed at age 14
- Lupus & You Q&A: Environmental Triggers and Flares
- Lupus Foundation of America Awards New Grant Supporting Research to Predict and Prevent Lupus in At-Risk Populations
- UPDATE: FDA Grants Cullinan Therapeutics Clearance for Application to Investigate CLN-978 for the Treatment of Systemic Lupus Erythematosus, Phase I Trial to Begin Soon
- UPDATE: Kezar Life Sciences Terminates Phase 2b Study of Zetomipzomib for Lupus Nephritis Treatment
- Vinita O. - Diagnosed at age 13
- New Study Identifies Four Distinct Systemic Lupus Erythematosus Disease Progression Patterns
- Scientists Identify Key Biomarkers That May Predict Low-Dose IL-2 Treatment Efficacy in People with Systemic Lupus Erythematosus
- Cynthia S. - Diagnosed at age 21
- Joanna S. - Diagnosed at age 24
- Trude T. - Diagnosed at age 16
- Aneshia B. - Diagnosed at age 37
- GSK Set to Acquire CMG1A46 from Chimagen Biosciences
- UPDATE: Ventus Therapeutics Announces Positive Phase 1 Trial Results for Investigational Drug, VENT-03, for Lupus
- New Study Finds Vitamin D Levels Could Influence Pregnancy Outcomes for Women with Systemic Lupus Erythematosus
- Leaders in Lupus Research Receive Prestigious Awards from Lupus Foundation of America for Significant Contributions to the Field
- UPDATE: Seattle Children’s Now Enrolling Participants for First U.S. CAR T Cell Clinical Trial for Children with Systemic Lupus Erythematosus
- Researchers Identify Potential New Gene Biomarker for Diagnosis and Evaluation of People with Systemic Lupus Erythematosus
- Study Examines Various Therapeutic Options for Lupus Nephritis and their Effectiveness
- Lupus Foundation of America Latest Research Achievements to be Featured at the 2024 American College of Rheumatology Annual Meeting
- Lupus & You Q&A: Managing Relationships
- Catherine R. - Diagnosed at age 22
- ACR 2024 - New Guideline for the Screening, Treatment and Management of Lupus Nephritis
- Jamie F. - Diagnosed at age 22
- Lupus Research Highlights From American College of Rheumatology’s 2024 Scientific Meeting
- First Person Dosed with Investigational Therapy, ADI-001, for Treatment of Lupus Nephritis
- Honoring Native American Heritage Month: Advancing Lupus Awareness and Support in Tribal Communities
- Llaritza R. - Diagnosed at age 28
- Altered Brain Connectivity Linked to Cognitive Impairments in People with Systemic Lupus Erythematosus
- Investigational Therapy SC291 Receives FDA Fast Track Designation for Relapsed/Refractory Systemic Lupus Erythematosus
- NFL Players Champion Lupus Awareness in 2024 My Cause My Cleats Campaign
- Renal Response Associated with Greater Likelihood of Long-Term Renal Survival in People with Lupus Nephritis
- Impact of Demographics and Psychosocial Burdens on People with Systemic Lupus Erythematosus in the U.S.
- Study Examines the Complex Interaction Between Systemic Lupus Erythematosus and Thyroid Disorders
- Fate Therapeutics Announces Promising Initial Data from FT819 Phase 1 Study for Moderate to Severe Systemic Lupus Erythematosus
- High-Dose BI655064 Shows Promising Results in Improving Renal Outcomes for People with Lupus Nephritis
- Becoming a Support System: How the LFA Helped Kim in Her Daughter’s Lupus Diagnosis
- Maria A. - Diagnosed at age 15
- Mo'Nay S. - Diagnosed at age 39
- Dana T. - Diagnosed at age 35
- New Study Examines Progress and Challenges in Biologic Treatments for Pediatric Rheumatic Diseases Over 25 Years
- Deucravacitinib Outperforms Other Biologic Therapies for Treatment of Cutaneous Lupus Erythematosus
- New Study Finds Efficacy in Combined Belimumab Therapy in Children with Newly Diagnosed Childhood-Onset Lupus Nephritis
- New Study Identifies Two Potential Non-Invasive Diagnostic Biomarkers for Systemic Lupus Erythematosus and Lupus Nephritis
- People Living with Systemic Lupus Erythematosus Demonstrate Clinically Meaningful Improvement with Cenerimod
- New Study Highlights Evidence Gaps and Under-Representation in Lupus Nephritis Clinical Trials
- Southern California Resources for Those Impacted by Wildfires
- IGM Biosciences Halts Development of Two Investigational Treatments for People with Autoimmune and Inflammatory Diseases
- Lupus and Your Mental Health
- New Study Finds Systemic Lupus Erythematosus is a Risk Factor for Developing Multiple Cutaneous Lupus Erythematosus Subtypes
- New Study Suggests KLF2 May Play a Role in Neutrophil Regulation and the Development of Systemic Lupus Erythematosus
- Exagen Inc. Gains Approval for Advanced Lupus and Rheumatoid Arthritis Diagnostic Tests
- UPDATE: Phase 1 Trial Begins for Investigational Therapy, CB-010, for Lupus Nephritis Treatment
- Coping with the Mental Health Impacts of Lupus
- Running a Marathon with Lupus: Pushing Limits with Strength and Support
- New Study Identifies Predictors of Successful Glucocorticoid Discontinuation in Systemic Lupus Erythematosus Treatment
- Let’s Talk About Lupus
- Investigator-initiated Study of CNTY-101, for People with Autoimmune Diseases, Including Systemic Lupus Erythematosus and Lupus Nephritis Announced
- Catching Thoughts About Lupus
- Nyobie Gordon-Ricks’ Lupus Journey: Finding Power and Advocacy in the Face of Lupus
- Titilayo O. - Diagnosed at age 34
- Allogene Therapeutics’ ALLO-329 Received FDA IND Clearance for Autoimmune Disease Trial
- Centers for Medicare and Medicaid Services Announces Medicare Pricing for Two Progentec Diagnostics Tests Used in Systemic Lupus Erythematosus Treatment
- New Study Finds Racial and Gender-Specific Approaches May Boost Black Participation in Lupus Clinical Trials
- Black History Month 2025: Your Voice, Your Power
- UPDATE: Investigational CAR-T Cell Therapy ADI-001 Receives FDA Fast Track Designation for Refractory Systemic Lupus Erythematosus with Extrarenal Involvement
- UPDATE: Gazyva® Shows Superiority Over Standard Therapy for People with Active Lupus Nephritis
- Fasting During Ramadan with Lupus
- New Study Finds Anifrolumab In Addition to Standard of Care Treatment is Effective at Reducing Organ Damage Accumulation
- Conduit Pharmaceuticals Partners with Charles River Laboratories to Evaluate AZD1656 for Lupus Treatment
- 2025 National Kidney Month: Check in with Your Kidneys, Because Kidneys Can’t Talk
- Lupus & You Q&A: Holistic, Integrative and Lifestyle Approaches
- New Study Investigates the Role of microRNA-203 as a Potential Biomarker for Lupus Nephritis
- FDA Accepts Supplemental Biologics License Application for Gayzva for Treatment of Lupus Nephritis
- New Study Highlights the Impact of Flares and Persistently Active Disease on Organ Damage in People with Systemic Lupus Erythematosus
- New Study Evaluates the Modified NIH Scoring System's Effectiveness in Predicting End-Stage Kidney Disease in Latin American People with Lupus Nephritis
- Learn About the New Treatment Guidelines for Lupus Nephritis
- Congress Passes Fiscal Year 2025 Funding for Lupus Programs
- Highlights from the Systemic Lupus International Collaborating Clinics World Lupus Seminar on Africa
- Healthy Lifestyle Intervention Shows Promise for Individuals with Systemic Lupus Erythematosus
- New Study Identifies Potential Biomarkers for Predicting Effectiveness of Mesenchymal Stem Cell Transplantation Therapy in People with Systemic Lupus Erythematosus
- Lupus Foundation of America Announces LFA LIFT to Accelerate Development of New Lupus Treatments
- Conduit Pharmaceuticals Announces Advancements in Lupus Treatment Research
- Six Days, One Mission: Raising Lupus Awareness Through the Virtual 6 Challenge
- Holly’s Journey to Make Her Mark On Lupus
- Lupus Foundation of America Urges Administration and Congress to Preserve and Strengthen Essential Lupus Programs
- Novel Stromal Cell Study in Lupus Reaches Critical Milestone
- Protecting the Future of Lupus Research, Programs, and Care
- Crystal D. - Diagnosed at age 38
- Study Finds Certolizumab Pegol May Improve Pregnancy Outcomes in Women with Antiphospholipid Syndrome with or without Lupus
- Lupus & You Q&A: Understanding Fatigue and Pain Management
- Survey Highlights the Significant Impact of Cutaneous Lupus Erythematosus on People’s Lives
- Allogene Therapeutics’ ALLO-329 Receives FDA Fast Track Designation for Three Autoimmune Conditions, Including Active Refractory Moderate-to-Severe Systemic Lupus Erythematosus
- Study Identifies Novel Predictors of Cardiovascular Disease Risk in Women with Systemic Lupus Erythematosus
- Study Finds Frailty Index Can Help Predict Health-Related Quality of Life for People with Systemic Lupus Erythematosus
- 2025 Lupus Awareness Survey Executive Summary
- Lupus Unknown by Majority of Americans, Despite Widespread Prevalence
- Study Finds Potential Link Between Higher BMI and Disordered Eating Attitudes in Women with Systemic Lupus Erythematosus
- FDA Grants Regenerative Medicine Advance Therapy Designation for FT819 Being Studied for the Treatment of Lupus
- Data Suggests CAR-T Therapy Shows Promise for Lupus Treatment
- Global Survey from World Lupus Federation Finds Nearly Half of People with Lupus Report Kidney Involvement
- Lupus Advocates Unite on Capitol Hill to Protect Access to Care and Research Funding During Lupus Awareness Month
- Mother’s Day 2025: A Tribute to Lupus Warriors and the Families Who Stand by Them
- New Treatment Guidelines for Lupus Nephritis Shift Focus to Continuous Therapy
- New Treatment Guidelines for Systemic Lupus Erythematosus for Children and Adults
- Study Identifies Eight Domains to Define Treatment Response in Systemic Lupus Erythematosus Clinical Trials
- Study Finds Elevated S100A8/A9 Levels Linked to Cognitive Impairment in Those with Systemic Lupus Erythematosus
- Celebrating Men’s Health Month 2025: Honoring Men with Lupus
- Danielle E. - Diagnosed at age 26
- Ajah B. - Diagnosed at age 13
- Lupus Foundation of America Awards Summer Fellowship Grants to Seven Young Scientists Advancing Lupus Research
- Cullinan Therapeutics Announces Licensing Agreement to Develop Velinotamig for Treatment of Autoimmune Diseases Such as Lupus
- Julexa B. - Diagnosed at age 14
- Judith P. - Diagnosed at age 24
- Shayla M. - Diagnosed at age 30
- Luz H. - Diagnosed at age 21
- Lupus Foundation of America Urges Congress to Protect NIH Research Funding
- Phase II Trial of Lupus Treatment Enpatoran Shows Promising Signs of Efficacy in those with Systemic Lupus Erythematosus
- Lupus Foundation of America Awards Two Grants to Advance the Understanding of Childhood Lupus and Improve Disease Management
- FDA Approves Benlysta Autoinjector for Treatment of Children with Lupus Nephritis
- Sharing the Experience: Men Living With Lupus
- Coalition Statement on Senate Passage of H.R. 1
- Lupus Foundation of America Remains Committed to Protecting Lupus Community’s Access to Care Following Passage of H.R. 1
- Lupus & You Q&A: The Male Journey
- Alexandra E. - Diagnosed at age 16
- Study finds high prevalence of chronic kidney disease in people with systemic lupus erythematosus
- Lupus Foundation of America and Lupus Canada Award Research Grant to Study Aiming to Uncover the Causes of Fatigue in People with Lupus
- Hydroxychloroquine (Plaquenil) Associated with Early and Long-Term Benefits on Kidney Function in People with Lupus Nephritis
- Lupus low disease activity state as a realistic treatment goal to improve kidney function and reduce renal relapses for people with Lupus Nephritis
- Dr. Annette Shelby, Lupus Advocate
- Lupus Foundation of America and Arthritis Foundation Commission Research on 340B Drug Pricing Program's Impact on Rheumatoid Arthritis and Lupus Therapies
- Lupus Foundation of America Appoints Brad Rovin, MD, as Chair of its Medical-Scientific Advisory Council
- Senate Bill Continues Funding for Critical Lupus Research, Education and Awareness Programs
- Strands of Strength: Hair Care & Styling Tips for Life with Lupus
- Systemic Lupus Erythematosus-Specific Risk Factors Linked to Osteoporosis and Bone Fracture Development
- Study Explores Preload Deficiency in People with Systemic Lupus Erythematosus
- More Than Skin Deep: Ashara’s Journey with Discoid Lupus
- Lupus Foundation of America Awards Two Grants to Early Career Scientists Advancing the Understanding of Lupus and Potential New Treatment Pathways
- New Research by Lupus Foundation of America Identifies High-Impact Solutions to Address Health Disparities in Lupus
- Walk to End Lupus Now® Events Bring Connection, Hope and Impact in the Fight to End Lupus Across the Country
- Walking With Strength: Ivette’s Lupus Journey
- New study investigates role of lupus anticoagulant and anti-β2 glycoprotein in predicting pregnancy outcomes
- Health Benefits of Yoga for Lupus
- Meet the Runners Racing to End Lupus at the 2025 TCS New York City Marathon
- A Win for Critical Lupus Programs: Advocacy Works
- New Research Finds High Incidence of Severe Maternal Mortality in US Veterans
- Nuestra Voz, Nuestra Ciencia: Uplifting Hispanic Voices in Lupus Research
- Greater resilience linked to better mental health outcomes and health-related communication in childhood-onset systemic lupus erythematosus
- New study finds systemic lupus erythematosus associated with adverse outcomes in right heart failure
- New study confirms significant association between Epstein-Barr Virus infection and systemic lupus erythematosus
- Lupus & You Q&A: Aging with Purpose
- Hispanic Heritage Month 2025: Honoring Voices, Culture, and Community in the Lupus Journey
- Lupus Foundation of America Releases 2025 Impact Report
- Phase III TULIP-SC trial of SAPHNELO® self-administration demonstrates reduction in systemic lupus erythematosus disease activity
- Disease activity maintenance and prevalence in people with systemic lupus erythematosus with clinically active disease
- Morphological brain changes linked to mild cognitive impairment in women with systemic lupus erythematosus
- Stephanie H. - Diagnosed at age 12
- Kathia C. - Diagnosed at age 13
- Fasting During Yom Kippur With Lupus
- Lupus Foundation of America Engages FDA on Inclusion of Pregnant and Breastfeeding Women in Clinical Trials
- Be Prepared to Fight Flu and COVID This Winter
- What is Medicare Part D? Updates for 2026 Open Enrollment
- FDA Approves Gazyva® (obinutuzumab) for the Treatment of Adults with Lupus Nephritis
- Lupus Foundation of America Research Showcased at 2025 American College of Rheumatology Annual Meeting
- American College of Rheumatology Releases New SLE Guidelines
- Advancements in Lupus Care and Innovations from the ACR Convergence 2025 Meeting
- Lupus Foundation of America Honors Outstanding Achievements in Lupus Research
- Lupus & You Webinar Recap: After Dark - A Conversation on Sexual Health and Intimacy
- Food and Medication Assistance for People with Lupus
- Phase III Study Shows Positive Results for Gazyva® in Systemic Lupus Erythematosus
- Veterans, Lupus, and the Power of Support
- New study finds link between Epstein-Barr virus and the development of Systemic Lupus Erythematosus
- Nya O. - Diagnosed at age 12
- Kathleen R. - Diagnosed at age 38
- 8 Free Gifts to Give Yourself for a Healthy Holiday Season
- NFL Players Support Lupus Foundation of America for My Cause My Cleats Campaign
- Urge Congress to Finalize Funding for Critical Lupus Programs
- New study finds certain blood-derived biomarkers can identify Systemic Lupus Erythematosus disease activity
- New research shows that the Renal Activity Index for Lupus could help predict treatment response in adults living with lupus nephritis
- Navigating Pregnancy with Lupus: Latasha’s Story
- Study identifies potential new marker that may predict poor kidney outcomes in lupus nephritis
- New research links discrimination to worse Systemic Lupus Erythematosus-related symptoms and mental health outcomes
- Living Well with Lupus: Pain Management and Lifestyle Changes That Make a Difference
- Phase 2b JASMINE trial of nipocalimab demonstrates positive results for treatment of systemic lupus erythematosus
- New Phase III study results support self-administered Saphnelo as an effective treatment option for systemic lupus erythematosus
- New study identifies 15 herbal supplements to potential skin flare activity in people with autoimmune skin diseases
- Lupus Foundation of America and Carebox Partner to Provide Easy Way to Match to Lupus Clinical Trials
- U.S. House of Representatives Passes Legislation Totaling $27 Million in Funding for Lupus Programs
- Lupus & You Webinar Recap: Be Your Strongest Voice
- Your Lupus Treatment Roadmap: Understanding New Treatment Guidelines and What They Mean for You
- Biogen’s litifilimab receives FDA Breakthrough Therapy Designation to further develop treatment for cutaneous lupus erythematosus
- Be Fierce. Take Control.®: Danielle Storr’s Journey of Advocacy and Empowerment